ML20024E467
| ML20024E467 | |
| Person / Time | |
|---|---|
| Site: | La Crosse File:Dairyland Power Cooperative icon.png |
| Issue date: | 06/30/1983 |
| From: | Hennen E, Shafer P, Steele T DAIRYLAND POWER COOPERATIVE |
| To: | |
| Shared Package | |
| ML20024E466 | List: |
| References | |
| PROC-830630, NUDOCS 8308150088 | |
| Download: ML20024E467 (91) | |
Text
.- -
y_.- - /
l.A CROSSE B0II.ING WATER REACTOR (l.ACBWR) 0FF-SITE DOSE PAI.CUI.ATION MANUAI.
Prepared by:
P. W. Shafer E. H. Hennen T. A. Steele June, 1983 Dairyland Power Cooperative 2615 East Avenue South I.a Crosse, WI 54601 B308150088 830805 PDR ADOCK 05000409 P
.c t
l TABLE OF CONTENTS 1.
INTRODUCTION 1
1 2.
LIQUID RELEASES 2.1 Compliance with Specification 4.3.1.2 4
2.2 Compliance with Specification 4.3.1.3 6
3.
GASEOUS RELEASES 3.1 Compliance with Specification 4.3.2.2 14 & 18 3.2 Compliance with Specification 4.3.2.3 22 3.3 Compliance with Specification 4.3.2.4 25 APPENDIX A - LACBWR Site Specific Factors...............
A-1 APPENDIX B - Stable Element Transfer and Bioaccumulation Factors B-1 APPENDIX C --Inhalation and Ingestion Oose Commitment Factors...................
C-1 APPENDIX 0 - Dose Factors for Exposure to a Semi-Infinite Cloud of Nobl e Gases........ -..........
0-1 APPENDIX E - Listing of Radiological Decay Constants ( Aj).......
E-1 ii WP4.15'
-i I
LIST OF TABLES 4-l 2.1 Dose Factors for 10 CFR 50 Liquid Releases.0DFi r....
10-11 3
3.1 10 CFR Part 20 Gaseous Releases infant Dose Factors 34-37 i
3.2 Atmospheric Dispersion Constants................
38-39 r
3.3 10 CFR 50 Ground Dose Factors 40-41 i.
3.4 10 CFR Part 50 Gaseous Releases Chi l d Dose Factors.......................
42-45 3.5 10 CFR Part 50 Gaseous Releases Infant Dose Factors 46-49 i
4 1
I r
4 I
iii I
L
- WP4.15 i
,,--,,, ~.-
m,
.m.,..
.~,
1 LIST OF FIGURES 2.1 10 CFR Part 20 Liquid Releases..................
12 2.2 10 CFR 50 Liquid Releases 13 3.1 10 CFR Part 20 Gaseous Releases Noble Gases 50 3.2 10 CFR Part 20 Gaseous Releases Noble Gases 51 3.3 10 CFR Part 20 Gaseous Releases Noble Gases 52 3.4 10 CFR 20 Gaseous Releases Particulate 00ses 53 3.5 10 CFR 20 Gaseous Releases Particulate Doses 54 3.6 10 CFR 20 Gaseous Releases Particulate Doses 55 3.7 10 CFR 20 Gaseous Releases Particulate Doses 56 3.8 10 CFR 20 Gaseous Releases Particulate Doses 57
.3.9 10 CFR 20 Gaseous Releases Particulate Doses 58 3.10 10 CFR 50 Gaseous Releases Noble Gas Doses 59 3.11 10 CFR Part 50 Gaseous Releases Particulate Doses 60 3.12 10 CFR Part 50 Gaseous Releases Particulate 00ses due to Tritium.................
61 3.13 10 CFR Part 50 Gaseous Releases Particulate 00ses due to Ground Plane 62 3.14 10 CFR Part 50 Gaseous Releases Particulate 00ses 63 I-iv WP4.15
o i
1.
INTR 0 DUCTION The purpose of the Offsite Dose Calculation Manual (00CM) is to describe the methodology and parameters to be used in the calculation of instantaneous release rate alarm setpoints and dose commitments due to radioactive materials released in liquid and gaseous effluents from the Lacrosse Boiling Water (LACBWR) to areas beyond the EFFLUENT RELEASE BOUNDARY. The LACBWR Technical Specifications enumerate the limiting conditions for operation:
Speci fication 4.3.l.2 "The concentration of radioactive material released in liquid effluents at any time to areas beyond the EFFLUENT RELEASE BOUNDARY shall be limited to the concentrations specified in 10 CFR Part 20, Appendix B, Table II, Column 2,...
for radionuclides other than dissolved or entrained noble gases. For dissolved or entrained noble gases, the concentration shall be limited to 2 x 10-4 41/ml total activity."
Specification 4.3.1.3 "The dose or dose commitment to a MEMBER OF THE PUBLIC from radioactive materials in liquid ef fluents released to areas beyond the EFFLUENT RELEASE BOUNDARY shall be limited:
. During any calendar quarter to < 1.5 mrems to the total body'and a.
< 5 mrems to any organ, and
.b.
During any calendar year to < 3 mrems to the. total body and < 10 mrems to any organ." WP4.15 j
\\
Speci fication 4.3.2.2
'The dose rate due to radioactive materials released in gaseous effluents to areas beyond the EFFLUENT RELEASE BOUNDARY shall be limited to the following:
a.
The dose rate limit for noble gases shall be < 500 mrems/yr to the total body and < 3000 mrems/ year to the skin, and b.
The dose rate limit for I-131, I-133, H-3 and for all radioactive materials in particulate form with half lives greater than 8 days shall be <
1500 mrems/ year to any organ.'
Specification 4.3.2.3
'The air dose to a MEMBER OF THE PUBl.IC due to noble gases released in gaseous effluents to areas beyond EFFLUENT RELEASE BOUNDARY shall be limited to the following:
a.
During any calendar quarter, to < 5 mrads for gamma radiation and
< 10 mrads for beta particle radiation, and b.
During any calendar year, to < 10 mrads for gamma radiation and < 20 mrads for beta particle radiation.'
Speci fication 4.3.2.4
'The dose to a MEMBER OF THE PUBLIC from I-131, I-133, H-3 and all radionuclides in particulate form with half-lives greater than 8 days, in gaseous effluents released to areas beyond EFFLUENT REI. EASE 80VNOARY shall.be limited to the following:
a.
During any calendar quarter to < 7.5 mrems to any organ, and b.
During any calendar year to < 15 mrems-to any organ.'
! WP4.15
r 1
t i
1 This manual contains calculational methods for determining alarm setpoints and also provides site specific dose factors for LACBWR.
The site specific dose factors enable the calculation of cumulative dose contributions to be performed at least once every 31 days, as required by the I.ACBWR Technical Specifications, to demonstrate compliance with the aforementioned require-ments.
f i
L l.
l l 'WP4.15
o o
2.
LIQUID RELEASES 2.1 Compliance with Specification 4.3.1.2 To assure compliance with Technical Specification 4.3.1.2, alarm setpoints must be calculated for each radioactive liquid effluent line monitor and flow measurement device.
The following equation is used to calculate setpoints:
cf
< C (2.1 )
F+f where:
C = the ef fluent concentration limit implementing 10 CFR 20 for LACBWR, in IC1/ml.
c = the setpoint of the radioactivity monitor measuring the radioactivity concentration in the effluent line prior to dilution and subsequent release; the setpoint, which is inversely proportional to the volumetric flow of the effluent line (f) and proportional to the volumetric flow of the dilution stream plus the effluent stream (F+f),
represents a value which, if exceeded, could result in concentrations I
exceeding the limits of 10 CFR 20 in the unrestricted area, in pC1/ml.
f = the effluent line' volumetric flow setpoint as measured at the radiation monitor location, in gallons per minute.
F = the dilution stream (LACBWR & G-3' Condenser Cooling Water) volumetric flow, in gallons per minute.
l-
=
l -
WP4.15
I e
f
(
I, Since f G F, Equation 2.1 is satisfied when the following alann setpoint is met:
f < Cf (2.2)
C Calculation of Instantaneous Allowable Release Rates LAC 8WR's liquid radwaste are released in batches.
In order to assess the allowable release rate,. f, the following step-by-step method for obtaining data will be performed. The form presented in Figure 2.1 may be used as a worksheet for these calculations.
1.
Go to Figure 2.1.
Enter the batch identification and date on the form.
2.
From the gamma isotopic analysis of the liquid radwaste in the tank to be released, the nuclide identification and concentration, in tCi/ml, of each nuclide are tabulated. Also to be tabulated are the MPC values from 10 CFR Part 20 Appendix B for the identified radionuclides, in iCi/ml.
3.
The quantities I Ci and E Ci are determined and recorded.
1 i
MPCj 4.
The alarm setpoint c, of the radioactivity monitor measuring radio-activity of the effluent line is determined by c = 1/2 E Ci i MPCj 5.
The value of F is determined and recorded at the top of the form.
F is the total dilution flow volumetric at the LACBWR - Genoa-3 outfall which is equal to the LACBWR condenser cooling water flow rate plus the Genoa-3 condenser. cooling water volumetric flow, in gallons per minute. WP4.15
e t
1 The maximum allowable flow rate from the liquid radwaste tank is calculated by:
f=1 F
(2.3) 2 E C1 i
MPCj 2.2 Compliance with Specification 4.3.1.3 To demonstrate compliance with Technical Specification 4.3.1.3, dose contributions are calculated at a maximum interval of every 31 days for all radionuclides identified in liquid effluents released to unrestricted areas using the following expression:
1 m
Dr = iI(Ai I
Cj g T )
(2.4) r g
t=1 where:
the cumulative dose commitment to the total body or any organ t,
0
=
7 from the liquid effluents released in m batches, in mrem.
a dilution factor accounting for dilution of the discharge by the 0
=
body of water into which it is released.
Ctt= the average quantity of radionuclide i, released by batch 1, in Ci.
Air = the site related ingestion dose commitment factor to the total body or any organ T for each identified principal gamma and/or beta emitter, in mrem-gal per min - C1.
Fg the dilution water flow rate factor in gallons / minute.
=
i l
- WP4.15 l
~
. Equation 2.4 requires the use of a dose factor Aj7 for each nuclide, which embodies the dose factors, pathway transfer (e.g., bioaccumulation factors,)
pathway usage factors, and dilution factors for the points of pathway origin.
The dose factor Aj 7 may be written:
Aj r =
Ko (U /0w + UpBFj) DFLj1 (2.5) w where:
a units conversion factor, 5.03 x 105 Ko
=
(1012 pCi/Ci x.2642 gal /1) + (8760 hrs /yr x 60 min /hr).
Uw the water consumption usage factor, in kg/yr.
=
the fish consumption usage factor, in kg/yr.
Up
=
BFj = the bioaccumulation factor in fish for nuclic'e i, in pCi/kg per pCi/1 OFLj 7 = the ingestion dose factor for nuclide i, in organ T, in mrem /pCi.
the dilution factor from the combination of LACBWR and Genoa-3's D
=
w condenser cooling water flow rates, and the 0 = 20.6 for Thief Slough dilution.
The following site-specific factors are incorporated into the liquid dose calculational model.
1.
Liquid dose pathways.
Due to LACBWR's status as a fresh water site, there is no invertabrate pathway. Also, the drinking water pathway shall be neglected, as the nearest community which obtains its drinking water supply from the Mississippi River l
is located at Davenport, Iowa, which is 195 miles downstream.
This represents I
7-WP4.15
e
<0.01% of the dose to any organ.
The significant pathway remaining is the dose commitment due to ingestion of fish from the Mississippi Piver waters.
l 2.
Age group.
Based on previous calculations, doses to the teenager and adult are l
approximately the same. 00scs to these age groups exceed those to the infant and child due to their relatively high fish consumption. Accordingly, doses will be calculated for the adult age group.
3.
Dilution.
The factor Fg, in Equation 2.4 is the combined total discharge flow rate f rom LACBWR and Genoa-3 during release of batch 1 (0 is set equal to 20.6 to account for additional dilution in the waters of the Thief Slough.)
As a result of the aforementioned site-specific criteria, Equations 2.4 and 2.5 are combined to yield the following expression:
1 KoVF-I~(BFj OFLj 7 $
Cj gTg)
(2.6) 0
=
7 0
i 1*l
_ Calculation of Dose Commitments Due to Liquid Effluents The calculation of dose commitments may be simplified by calculating the factors Ko Up BFj 0FLj7 for each radionuclide i, for each. organ T, of an
-~ dult. The values of Up, BFji and DFLj7 may be found in Regulatory Guide a
1.109 and in Appendices A, B, and C of this manual. The tabulated values of K Up' BFj OFLj r may be found in Table 2.1, and are called 00 Fir.. ' Equation 2.6 o
t WP4.15
'1
=-
-2
l may then be reduced to:
1 I (00 Fir E Cj g 7g)
(2.7)
Dr
=
i tal Osing Figure 2.2 and following the procedure outlined below, the dose comnitment to each organ, D, may be calculated.
1 1.
Go to Figure 2.2.
Enter date and the batch identifications of each batch released.
2.- Enter the average dilution flow rate, Fg, during the month in gallons / min.
3.
Enter.all nuclides identified as being released during the month.
4.
In the. column ECj g, enter the total quantity of each nuclide released t
in the i batches identified, in C1.
5.
Enter the dose factors, ODFj r, from Table 2.1, for each organ and nuclide released.
6.
Compute II Cj g DDFj r for each organ.
t
'7 Calculate the total dose received by each organ by dividing EE Cj g ODFj r by Ft..
o 11 r
i
- WP4.L b '
Table 2.1 DOSE FACTORS FOR 10 CFR 50 LIQUID RELEASES 00 Fir Nuclide Bone Liver Total Body Thyroid Kidney Lung GE-LLI H-3 NO DATA 4.85 E-2 4.85 E-2 4.85 E-2 4.85 E-2 4.85 E-2 4.8 5 E-2 NA-24 8.71 E+1 8.71 E+1 8.71 E+1 8.71 E+1 8.71 E+1 8.71 E+1 8.71 E+1 CR-51 NO DATA NO DATA 2.73 E-1 1.63 E-1 6.01 E-2 3.62 E-1 6.86 E+1 MN-54 NO DATA 9.73 E+2 1.79 E+2 NO DATA 2.79 E+2 NO DATA 2.87 E+2 FE-59 2.22 E+2 5.23 E+2 2.00 E+2 NO DATA NO DATA 1.46 E+2 1.74 E+3 CO-57 NO DATA NO DATA NO DATA NO DATA NO DATA NO DATA 2.36 E+1 C0-58 NO DATA 1.91 E+1 4.28 E+1 NO DATA NO DATA N0 DATA 3.87 E+2 C0-60 NO DATA 5.48 E+1 1.21 E+2 N0 DATA NO DATA NO DATA 1.03 E+3 ZN-65 4.96 E+3 1.58 E+4 7.13 E+3 NO DATA 1.06 E+4 N0 DATA 9.94 E+3 SR-89 4.73 E+3 NO DATA 1.36 E+2 NO DATA NO DATA NO DATA 7.59 E+2 SR-90 1.17 E+5 NO DATA 2.86 E+4 NO DATA NO DATA NO DATA 3.37 E+3 SR-91 8.72 E+1 NO DATA 3.52 NO DATA NO DATA NO DATA 4.15 E+2 SR-92 3.31 E+1 NO DATA 1.43 NO DATA NO DATA NO DATA 6.55 E+2 Y-91M 1.16 E-3 NO DATA 4.51 E-5 NO DATA NO DATA N0 DATA 3.42 E-3 Y-91 1.81 NO DATA 4.83 E-2 NO DATA NO DATA NO DATA 9.94 E+2 Y-92 1.08 E-2 N0 DATA 3.16 E-4 NO DATA NO D ATA NO DATA 1.90 E+2 ZR-95 5.14 E-2 1.6 5 E-2 1.12 E-2 NO DATA 2.59 E-2 NO DATA 5.23 E+1 N8-95 9.56 E+1 5.32 E+1 2.$6E+1 NO DATA 5.26 E+1 NO DATA 3.23 E+5 WP4.15
I
{
i I
w w
N N
W w
W M
M e
w M
W M
N
+
4
+
+
+
+
+
+
+
3
+
6
+
+
+
J W
W W
W W
W W
HHHHH W
W W
W W
W W
W
_f
< a:r a:r < <
0 N
N N
w N
W M
C0000 W
W N
N 2
4 W
M W
M M
W w
W N
N O
W W
N W
M N
W N
O e
o e
e e
e e
e e
o e
o e
e bcomeEZ2f N
N m
M M
2 W
M e
m a
w M
4 e
N t
I
+
+
t H
W W
H H
H H
H HHHHH W
W W
H H
H H
C 2
O M
W O
O O
O O
C0000 M
W d
O O
O O
J W
N W
N b
b b
N N
N N
w w
w w
w 4
e W
N M
N M
+
1
+
+
+
+
+
+
+
+
1 t
i I
O W
W W
W W
W W
HHHHH W
W W
W H
W W
W C
D O
W O
N N
4 M
M OOOOO M
m Q
M O
N N
N O
N m
m.
W N
m M
m.
N.
e O
M V
e e
e e
e e
OO no e
e o
e e
e W
W w
M N
N M
w ZZ ZZ 4
M M
Z w
W W
m V
W M
N U
+
+
+
u e
H H
H H
H W
W W
HHHHH H
H H
H H
H H
H C
O O
L O
O 3
O O
O m
O C0000 O
O Q
O O
O O
O U
h W
N m
h b
b b
b b
5 bbbbb b
b b
b b
b b
b N
t M
M e
t N
h V
N M
w W
e w
M e
N W
O O
e i
e
+
+
+
+
e e
e s
m W
W W
W HHHHH W
W W
W W
W W
D m
~
O M
W m
W N
m m
C000Q 4
N M
M N
2 M
H m
N m
W O
N W
W N
N M
W N
N O
M
'M p
e e
o e
o e
e e
cocoq e
o e
e e
o e
e K2ZZ~
w N
W N
e M
w M
O W
M 4
N W
M W
W M
M W
W W
N N
N M
M
+
6
+
+
+
+
+
I I
I e
I L
W W
H H
W W
HHHHH W
W W
W W
W W
W W
M N
M O
O N
O N
00000 N
N N
M M
e W
O e
N M
W W
G m
W M
N O
N O
O J
e o
e m
o e
e e
moomm o
e e
o e
e e
e N
4 e
2 Z
e m
2ZZ22 w
W s
M M
W M
m e
M M
a e
e s
m N
M M
M s
e t
+
+
+
+
+
+
+
e e
e e
e H
W W
W W
W W
HHHHH W
W W
W W
W W
W C
O O
O w
2 M
O m
M OOOOO N
N O
O O
O O
O m
W 4
4 N
O W
M W
M N
m W
M q
q q
e o
e e
o e.
e e
e e
e e
o e
e u
M m
m M
M w
M W
m W
M e
N W
~
~
D TE T
U T
M W
M W
-MMMW e
N m
O O
M e
m e
m m
m O
O M
M M
MMMMM M
M M
M
~
m M
M w
w Mmwww a
m M
M M
M M
N U
e e
I O
t i
I e
a e t I I I
e I
t t
I I
I W
3 m
O O
D D
w w
w WWWWW W
W M
W W
M Z
E H
H E
E XXXXX U
U U
m J
U U
Z e
e A3
id y
M PG
)
2 e
l baT F
B no x
i e
i t
t d
aea n
ct R e
i a p
fDw p
i o
A 5
4 5
55 4
5 4
6 5
5 5
7 7
6 5
4 3
5 4
4 4
6 t
l 0
9 0 00 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 n
F e
0 E E E
E E E E E E E E E
E E E E
E E E E
E E E
d n
2 I
o 3
1 2
1 9
1 5
1 9
1 6 8' 3 3
1 9
4 2
2 l'
1 8
3 i
t I
h t
r C
P c
u a
M t
l P
/
a i
B D
R y
ic F
4 C
EI 0
1 S
(
+
E i2 S
i 5
A C
o, s
1 E
P f
L M
s E
p i
R k\\
D t
1 I
2 Q
I U
s 3
e I
)
e L
l 2
f y1 r
m
~
u 0
/
+.
f' c,
g 2
i i
C F
T t
e R
(
A 5
P i
~
c f
1 R
- ,T F
C k
,+
n
/
1 0
a 1
T n
t
., \\, '
=i,.
i
/
= "
n i
- a. -
o_
i c
1
'T C t
I'i C P '
a n Y, 1
r
\\
x 4
t II s'
n 2
6
's e
. 2 c
n 7+
o t
/ <,
c C
s
+
t 3
a
+
t
. y.
1 g'.
g i
e s
, j'.
o f
~
__b
)
)
_ i i
_ r
'+
h.
a p
L
_f
[t..
i R
d onseoneb surur eo r (a e e,r yr e
l h
e p^
+
s CMCCCZFNCR2RS17ccJBXXpS i
T lM 40 3 i 3 5 59 3
)t l
O 4 7 ' 8 5 95 " 6 53 0 1 t
3 j 5 4 3 358 c
c "5 3 45 6593 0 90 93 i1 1 a
N q
s 5
u 1 1 1 1 1
1 Ii s
s(
1 1
J fw 3
5 d
f 4
- 7
.P W,.
3 t
/
r-
' i f[ r -[r ~
6 tp
I Figure 2.2 10 CFR 50 LIQUID RELEASES Release Batch Identifications, 1 Date Dilution Flow Rate, Fg gal / min.
ECg 00Fj ODFj 00Fj 00Fj 00Fj 00Fj 00Fj 00Fj l
i Nuclide 1
(Skin)
(Bone)
(Liver)
(T.B.)
(Thyroid)
(Kidney)
(Lung)
(GIfLI)
- TO i
5%n' 437Cs 14Te STO i
65Zn 59pe 95Nb A34g3 10%u(Rh) 95sr i
'03Ru 90Sr i
i311 3
133g 141Ce 57(n SICr 440Ba(La) i 133Xe 135xe i
55pe 893p I I C g00Fj r i
1.1 C g00 Fir i
01= EI 11 Fg WP4.15
3.
GASEQUS RELEASES 3.1 Compliance with Specification 4.3.2.2 To assure compliance with Technical Specification 4.3.2.2, alarm setpoints are established for the gaseous effluent monitor..These setpoints are calculated and confirm that the current setpoints are set correctly for one and two stack blower operation under the following condition:
a.
A change occurs in the spectrum of nuclides released.
b.
At a minimum, once every year, or as required by procedure.
The following mathematical relationships shall be used to implement the above specification for noble gas release alarm setpoints:
6T
[ Qj (J) DFBj ]
(3.1 )
K' E
=
4 US
{ 1.11 x I [ Qt (J) DFJ ]
K'
=
q
[ Qi (J) DFSj ] }
,(3.2)
+
E 9
where:
6T the dose rate to the total body of an individual beyond the
=
EFFLUENT RELEASE BOUNDARY due to noble gases. This value
~is to be less than 500 mrem /yr. WP4.15L
l l
\\
l l
l l
a constant of unit conversion,106 K'
pCi/Wi.
=
the release rate of nuclide i, in Wi/sec.
Qj
=
(,1) the atmospheric dispersion coefficient (corrected for
=
q radioactive decay,) for instantaneous releases in sec/m3. For gaseous release monitor setpoints, 6.0 x 10-5 sec/m3 is used, based upon Regulatory Guide 1.3 criteria.
DFBj the total body gamma dose factor for exposure to a
=
semi-infinite cloud of noble gases, in mrem-m3 per pCi-yr.
- S D
.the dose rate to the skin of an individual at or beyond the
=
EFFLUENT RELEASE BOUNDARY due to noble gases. This value is to be less than 3000 mrem /yr.
1.11 the ratio of the tissue to air absorption coefficients over
=
the energy range of photons of interest. This converts dose (mrad) to dose equivalent (mrem).
DF7 the_ gamma dose factor for exposure to semi-infinite cloud of
=
1 noble gases, in mrad-m3 per pCi-yr.
OFSj the skin beta dose factor for exposure to a semi-infinite
=
cloud of noble gases, in mrem-m3 per pCi-yr.
NOTE:
Equations 3.1 and 3.2 incorporate the use of the semi-infinite plume model.
The model assumes receptor submersion in a plume of uniform concentration, which is semi-infinite in geometry, having as its only boundary the ground plane. Due to the meteorology and topography at Lacrosse site, the worst
. receptor locations are a bluf_f 1300 m SSE and a bluff 600 m ENE of the f acility. ~ At these locations the receptor is submerged in the plume.
~ WP4.15
m a
Calculation of Instantaneous Release Rate Limits for Noble Gases
. Equations 3.1 and 3.2 are used to calculated the controlling instantaneous release' rate setpoints for dose rates to the total body and skin of an individual due to noble gases for one and two blower operation. These equations may be simplified by calculating the ratio of each nuclide i, to the total release rate Dij. The atmospheric dispersion constants used for this i
]
purpose is established at 6.0 x 10-5 sec/m3 based upon Regulatory Guide 1.3 criteria.
The ratio of each nuclide i to the total release rate DQj shall be calculated i
I j
on a monthly basis, or as necessary, using F.gure 3.1.. The resulting ratios, T
RNGi, are multiplied by DFBj, DF7, and DFSj as applicable, and tabulated in i
Figure 3.2.
The resulting values are multiplied by 6.0 x-10-5 sec/m3, and the conversion constants, from which the values TBF, SFG and SFB result in Figure 3.3.
The values TBF, SFG and SFB for one and two blower operation are i
i inserted into the following equations from which the release rate. limits are
- computed:
i ;
=
(500 mrem /yr)
'(3.3)
TBF 6
(3000 mrem /yr)'
(3.4)
=
.(SFG + SFB)
. where:
0 the total allowable release concentration, in pCi/cc.
=
4
.- 161-WP4.15'
i i
The following step-by-step procedure is used in conjunction with Figures 3.1, 3.2 and 3.3 to calculate the instantaneous release rate limits for noble gases for one and two stack blower operation.
1.
Start on Figure 3.1.
Enter the date.
2.
Enter the name, nuclide i, and the release rate Qj, in Wi/sec, of each identified noble gas in tne gaseous effluent as measured by the marinelli grab gas sample from the SPING at stack. At the bottom of the form, compute the sum of the release rates, dj, 41/sec.
3.
Under the column labeled RNGi on Figure 3.1, enter the ratio of the release rate of each nuclide i to the total release rate dj.
i 4.
From Appendix D, enter the values of 0FBj, DF7 and DFSj for each of 1
the identified nuclides.
5.
Go to Figure 3.2.
Enter the date and each identified nuclide 1.
6.
From Figure 3.1, the values of Rggj are multiplied by DFBj, DFY and 1
0FSj, and tabulated in the appropriate columns in Figure 3.2.
The sums are computed and entered at the bottom of the respective columns.
Y 7.
Go to Figure 3.3.
Note the value of 6.0 x 10-5 sec/m3 for q.
8.
Uring the equations at the top of Figure 3.3, calculate the values of TBF, SFG and SFB for one and two blower operation, taking the RNGi 0FBj, RNGi DFy and RNGi DFSj values from Figure 3.2.-
i 9.
Next calculate the values of h and select the lower value. The lower valuesof6socalculatedforeachtypeofbloweroperationbecomethe-alarm setpoints for noble gas releases. WP4.15
1 4
f The following mathematical relationship shall be used to implement Specification 4.3.2.2 for 1131, 1133, H3 and particulates with Tl/2 >8 days alarm setpoints:
OP i [Pj W6j]
(3.5)
I
=
7 where:
4 UP the dose rate to organ T of an individual at or beyond the
=
EFFLUENT RELEASE BOUNDARY, due to 1-131, 1-133, H-3 and particulates with half-lives greater than 8 days. This value is to be less than 1500 mrem /yr.
Pj y the dose parameter for organ t, for radionuclides other than
=
noble gases, in mrem-m3 per Wi-yr for the inhalation pathway.
W the highest calculated annual average dispersion' parameter
=
for estimating the dose to an individual at the controlling location for long term releases (for previous months of the year) -in sec/m3 for the inhalation pathway.
Calculation of Release Limits for 1131, 1133, H3 and Particulates with Half Lives Greater than 8 Days Since it is impractical to measure instantaneous release rates for-radio-nuclides' other than noble gases, the alarm setpoints for radionuclides other than noble gases are expressed in tenns of total accumulated activity on sample media for a specified -sampling time, dT which is monitored as 41 by the stack (SPING) effluent monitor. -
WP4.15
Equation 3.6 is used to calculate the release rate limit for all I-131,1-133, H-3 and particulates with half lives greater than 8 days. This equation
-calculates dose rates due to infant inhalation of these radionuclides. The worst receptor locations are a bluff 1300 m SSE and a bluff 600 m ENE of the facility for ground plane exposure and inhalation pathways.
(Although not considered in the alarm setpoint calculation, for the cow-milk pathway, the worst pasture locations are a bluff 1300 m SSE and a bluff 1000 m ENE of the plant.)
In accordance with NUREG-0133, the infant will always receive the maximum dose rate under the exposure conditions for Specification 4.3.2.2.
The atmospheric dispersion coefficient (Y/q) used is 6.0 x 10-5 sec/ m3 based upon criteria of Regulatory Guide 1.3.
Alarm Setpoint Calculations for 11 31, 1133, H3 and Particulates withHalfLivesGreaterthan8 Days; Qpr 1500 mrem /yr -
=
Ej [ Pj 7 ( Sh31ation) x RPj] [Jj KG (3.6) q.
where:
the total release rate of radionuclides in 41/sec.
Qp7
=
the fraction of each nuclide i, other than noble gases, Rpj
=
to the total release rate of nuclides other than noble gases.
the atmospheric dispersion factor for instantaneous releases, Y
-=
q 6.0 x 10-5 sec/m3, based upon criteria of Regulatory Guide 1.3.
a constant of unit conversion,106 Kc pCi/41.
=
Resolution of the Pj7 term in Equation 3.6 yields: WP4.15
Pj 7 (inhalation)
K' (BR) (DFAj7)
(3.7)
=
where:
K' the constant of unit conversion 8760 hrs /yr.
=
the inhalation dose factor for an infant, for the ith DFAj 7
=
radionuclide, for organ t, in mrem /pCi.
3 BR infant breathing rate, in m /yr.
=
To calculate the alarm setpoint in terms of total WCi deposited on filter or cartridge sample media, the following equation is used:
Lowest Qp7 x dF 6p1 (3.8)
FR where:
LCi/sec Qp r
=
FR stack flow rate, cc/sec
=
dF totc1 flow through sample media, cc.
=
0p7 pCi (deposited on sample media in sample time dT).as
=
monitored by stack effluent monitor.
Following the procedure outlined below, calculate the release limits for radionuclides other than noble gases. This will be done on at least an annual basis.
1.
Start on Figure 3.4.
Enter the date.
2.
Enter the name, nuclide 1, and the release _ rate, Qpj, in pCi/sec, of each identified radionuclide. At the bottom of the form, compute and enter the sum, EQpj = Qp.
! L WP4.15 l-
3.
Under the column labeled Rpj, enter the ratio of the release rate of nuclide i to the total release rate @pj.
i 4.
From Table 3.1, enter the values of Pj 7 (infant inhalation) for each identified nuclide, under the appropriate columns.
5.
Go to Figure 3.7.
Enter the date and the name of each nuclide 1, identified in the gaseous releases.
6.
In the appropriate column, for each organ T as identified on the top of the form, compute and enter the values of Rpj [Pj7 (inhalation)].
g:
The values of Rpj are taken from Figure 3.4.
7.
Go to Figure 3.8.
Enter the date and name of each nuclide i, identified in particulate / cartridges sample media taken from gaseous releases.
8.
For each organ T, as noted at the top of the forms, calculate and enter the value of J Rpj [Pj7 (inhalation)] for each nuclide. J is 6.0 x 10 9 9
sec/m3 based upon criteria of Regulatory Guide 1.3.
At the bottom of the column, calculate and enter the sums.
9.
Go to Figure 3.9.
Enter the date.
4
- 10. Using the equation at the top of Figure 3.9, calculate the release rate limits, Qp7, for each organ T.
11.
Select the lowest value of Qp7, enter at the bottom of Figure 3.9 under appropriate blower operation. Multiply the Qpr number times the total sample flow through the sample media, cc, and divide this by the appropriate blower flow rate, cc/sec, to determine the Qpr(iCi).
These will become the instantaneous release alarm setpoints for 1131, g133, H3 and'particulates with half lives greater than 8 days.
i WP4.15 i
3.2 Compliance with Specification 4.3.2.3 To demonstrate compliance with Technical Specification 4.3.2.3, dose contributions are calculated for ali radioactive noble gases identified in gaseous effluents released to unrestricted areas using the following expressions:
3.17 x 10-2 I 0FY [ [ )0 (r,0) Qj OY (r,0)
=
0
$3 (r,0)qj ]
(3.9)
+
q 3.17 x 10-2 I 0F8 [ [ )D (r,0) Qj 0 8 (r,0)
=
g)D(r,0)qj]
(3.10)
+
q where:
DY(r,0) the dose commitment to the maximum individual due to the
=
gamma radiation of noble gases at location (r,0), in mrad.
0 6 (r,0) the dose commitment to the maximum individual due to the
=
beta radiation of noble gases at location (r,0), in mrad.
the total release of noble gas radionuclide i, in gaseous Qj
=
effluents for long term releases (for previous months of the year) in $i.
qi the total release of noble gas radionuclide i, in gaseous
=
effluents for short term releases (for the past month), in Wi.
3.11x10-2 inverse sec/ year x pCi/pCi
=
$)0 the average atmospheric dispersion factor (corrected for
=
q
- [ ju (r,0) Qj does not apply to monthly dose calculations for'ist month. WP4.15
o J
radioactive decay) for short term releases (for past month) l at location (r,0), in sec/m3, 0
(3 the annual average atmospheric dispersion constant (corrected
=
for radioactive decay) for long term releases (for previous
. months of the year) at location (r,0), in sec/m3, F
1 i
Other terms in the above two equations have been previously defined.
As was previously stated in Section 3.1 of this manual, the meteorology and topography at the Lacrosse site submerge the receptor in the plume at the-l worst location.
(Equations 3.9 and 3.10 reflect this fact as they are i
semi-infinite plume models.)
l Calculation'of Ganna and Beta Air Dose Commitments In accordance with the Technical Specifications, the gamma and beta air dose commitments are to be calculated, as a minimum, once every 31 days. To 0
0 perform these calculations the values of 3 (r,0) and 3 (r,0), which are calculated and entered on Table 3.2, and which correspond to the-number of' stack blowers operating during the month, and the values of DFj Y and DFj S from Regulatory Guide 1.109 (see Appendix D), are inserted into Equations 3.9' and '
3.10.
i-The following step-by-step prccedure is used in conjunction with' Figure 3.L0 ~
to calculate the monthly cumulative dose commitments due to. noble gases. Note that if the number of stack blowers operating during the time period-for which the calculations are.being made changed, the following~ steps must be' performed twice: once using the atmospheric ~ dispersion constants = for one ' blower 23
!WP4'LS-(
,. -b_,--,__
pg y
=y,
I operation and the radionuclides released during one blower operation, and a second time using the atmospheric dispersion constants and radionuclide.
releases occurring during two blower operation.
The total dose is then the total of the two calculations.
1.
Go to Figure 3.10.
Enter the date on the form.
2.
Enter the name, nuclide i, and the total releases Qj and gj, in Wi, of each identified noble gas in the gaseous effluent.
3.
Enter the values of ( )D (r,0) and ( )D (r,0). The values of D
( )D (r,0) and 3 (r,0) used are the values at the critical receptor i t. cati on.
4.
From Appendix D, enter the values of DFj Y and DFj 8 for each of the identified nuclides.
5.
Compute the values of DFj Y Qj, DFj Yqi, DFj Qj, and DF8qj for each 0
nuclide i, and enter into the appropriate columns. At the bottom of these columns, calculate the sums of these factors.
6.
Calculate the dose commitments due to noble gases, DY(r,0) and 0 (r,0), using the equations at the bottom of Figure 3.10.
6
^
, W4.L 5
-~
e i
3.3 Compliance with Specification 4.3.2.4 To demonstrate compliance with Technical Specification 4.3.2.4, dose contri-butions are calculated for 1131, [133, H3 and particulates with half lives greater than 8 days, identified in gaseous effluents released to unrestricted areas using the following expression:
DP 3.17 x 10-8 I[MiTa (WQi + W41) ]
(3.11 )
=
Ta I
where:
OP the 00se commitment to organ T of the maximum individual in
=
Ta age group c. due to the release of radionuclides other than noble gases, in mrem.
3.17x10-8 the inverse of the number of seconds in a year.
=
Mi Ta the dose factor for organ T of the maximum individual in age
=
group a, for each identified radionuclide i, in m2 (mrem /yr) per $1/sec for the ground plane exposure and food pathings, or in mrem /yr per $i/m3 for the inhalation pathway.
the dispersion parameter for estimating the dose to an W
=
individual at the controlling location for long term releases (for the previous months of the year), in sec/m3 for the inhalation pathway and in m-2 for the food and ground plane exposure pathways.
the dispersion parcmeter for estimating the dose to an W
=
individual at the controlling location for short term releases (for the past month), in sec/m3 for the inhalation pathway and in m-2 for the food and ground plane exposure pathways. WP4.15
i in developing the Mi ta value, separate expressions are written for each of the existing pathways.
These values shall also consider two age groups, the child and the infant, as well as the various organs. The reason for considering two
' age groups and the various organs for each age group is to provide assurance that all pathways have been covered in the event that a radical departure from the normal spectrum of radionuclides released produces a high dose to a particular organ.
Expanding. equation 3.11, doses are calculated as the sum of the two equations presented below.
For all radionuclides except tritium:
P I
G 3.17 x 10-8 E [ Qj r (Mi ra
)DD(r,0) + Mi ta
)' (r,0)
Dr
=
C M
V
+ (Mita + Mita + Mi ta) ( ) (r,0) )]
I G
,I E qi (Mi ra (1)DD(r.0) + Mi ta (D ) (r, e)
+
q q
C M
V
+
(Mita + Mi ta + Mi ta) (D.) (F 8) )3 }
q (3.12) and for tritium:
P 1
Da= 3.17 -x 10-8 g [ gj (giu
)DD(r,0) i C
M V
+ (Mita + Mita + Mi Ta) ( )DD(r,0) )]
I E[qi (Mi ta
)DD(r 0)
+
C
.M V
i i Ta) @Q )DD(c',0) - )] }
(Mi ta + Mi ta + M l
+
(3.13) j WP4.15
For the Lacrosse site, the worst real receptors are at locations 1300 meters SSE and 600 meters ENE of the site for the inhalation and ground plane pathways. For the food chain pathways, the worst receptor locations are pastures L300 meters SSE and 1000 meters ENE the site. The corresponding atmospheric dispersion constants which are calculated and entered on Table 3.2 must be used when calculating doses.
I lnhalation Pathway Factor, Mi ta The inhalation pathway factor is resolved as follows:
I K' (BR)a (DFAj7)a (3.14)
Mi ta
=
where:
I the inhalation pathway factor for radionuclide 1, age group Mi ta
=
a, and organ t, in mrem /yr per Wi/m3 3
the breathing rate of the receptor of age group a, in m /yr.
BR
=
a the inhalation dose factor for the ith radionuclide, organ T,
OFAi ta
=
and age group a, in mrem /pCi.
G Ground Plane Pathway Factor, Mi ta The ground plane pathway factor is resolved as follows:
l g
- Aj t Mi ta K'K"(SF) DFGj x [(1 - e b )/ Aj]
(3.15)
=
where:
G
-Mi ta the ground plane pathway factor for radionuclide i, organ t,
=
and age group a, in m2-mrem /yr per 41/sec.
the shielding factor.
SF.
=
tb the ' exposure time, in sec.
=
. WP4.15
r C
Cow - _ Milk Pathway Factor, Mi ta The cow - milk pathway factor is resolved as follows:
i For all radionuclides except tritium:
QpUac
- Aj t '
h C
)e Fm r (DFLjr)a (
+(1 p _
) e-A tif K' Ai+Aw Mi Ta (3.16) and for tritium:
C K'K" E 0F ac (OFLj 7)a [0.75 (0.5/H)]
(3.17)_
U Mi Ta m
where:
C Mi Ta the cow - milk pathway factor' for radionuclide 1, organ T,
=
i 2
and age group a, in m -mrem /yr per sci /sec for all radio-3 for tritium.-
nuclides except tritium and in mrem /yr per tC1/m i
the receptor's milk consumption rate for age group a, in Vac
=
li ters/y r.-
0FLi Ta the ingestion dose factor for radionuclide i, organ T, and
=
age group a, in mrem /pCi.
the fraction of the year the. cow is on the pasture.
f
=
p the fraction of the cow feed that is pasture grass while.the fs
=
cow is on the pasture.
th = the transport time from pasture, to harvest, to cow, to milk,-
to receptor, in sec.
Ys = the agricultural productivity by unit area of stored feed, I ~
in kg/m2, i
i
-- WP4.15
- o 8
M
__ Cow _ Meat Pathway Factor, Mi ta The cow - meat pathway factor is resolved as follows:
For all radionuclides except tritium:
U OF am
- Aj t K' Ai + bff r (DFLjr)a ( b + (
p s)e h ) e-A t m M
if Mi ta Y
Y p
s (3.18) and for tritium:
M K'K" f 0F am (OFLj r)a [0.75 (0.5/H)]
(3.19)
U Mi ta t
1 where:
M Mi ta the cow - meat pathway factor for radionuclide i, organ t,
=
2 and age group a, in m -mrem /yr per Wi/sec for all radio-nuclides except tritium, and in mrem /yr per $1/m3 for tritium.
tfm the transport time from pasture to receptor, in sec.
=
the receptor's meat consumption rate for age a, in kg/yr.
Vam
=
Ff the stable element transfer coefficient for meat, in days /kg.
=
V Vegetation Pathway Factor, Mi ta The vegetation pathway factor is resolved as follows:
For all radionuclides except tritium:
y r
-AttL
- A t y) ih K'
(Yy (At + N)) (OFLj r)a (U f
I gg L *
+Uas g" Mi ta
=
(3.20)
-and for tritium:
M as g] [(DFLj r)a [0.75 (0.5/H)]
(3.21)
K' K'" [Ua t L + U f
f ta =
t-WP4.15
where:
V Mitu the vegetation pathway factor for radionuclide i, organ T,
=
and age group a, in n2-mrem /yr per 41/sec for all radio-nuclides except tritium, and in mrem /yr per pCi/m3 for t ri t ium.
the vegetation areal density, in kg/m2 Y
e y
UaA the consumption rate of fresh leafy vegetation by the
=
receptor in age group a, in kg/yr.
the fraction of the annual intake of fresh leafy vegetation fl
=
grown locally.
tt the average time between harvest of leafy vegetation and its
=
consumption, in seconds.
Uas the consumption rate of stored vegetation by the receptor in
=
age group a, in kg/yr.
the fraction of the annual intake of stored vegetation grown f
=
g locally.
ty the average time between harvest of stored vegetation and its
=
h consumption, in seconds.
Using the values of BR, SF, t, QF, Vac, A. A, Fm, r, f, fs, Y, Y, t e 1
w p
p 3
h and f, as provided by Regulatory F, Yy, Ua t F, t, Vas, t y t m, H, V me f
L t
h f
a g
Guide 1.109 and tabulated in Appendices A and B; and the values of UFAi r, DFGi r, and 0FLi r, as provided by Regulatory Guide 1.109 and tabulated in Appendix C of this manual; and inserting the known values of Aj, the pathway WP4.15
' ~
~
0 factors Mi ta may be calculated. The values of Mi ta for each of the five r
pathways and two age groups may be found in Tables 3.3, 3.4 and 3.5.
Calculation of Dose Commitments due to Releases other than Noble Gases Using the~ values of Mi ta from Tables 3.3, 3.4 and 3.5, and the total short term and long term releases of radionuclide i, qj and Qj, the dose commitments due to gaseous releases other than noble gases may be calculated on a monthly basis, using Figures 3.11 through 3.14, and following the procedure outlined below. Note that, if the number of stack blowers operating during the time period for which the calculations are being made changed, the following steps must be performed twice. Once using the atmospheric dispersion constants for one blower operation and the radionuclides released during one blower operation, and a second time using the atmospheric dispersion constants and radionuclide releases occurring during two blower operation. The total dose is then the total of the two calculations.
I 1.
Using the form of Figure 3.L1, calculate EMiTa Qi for the inhalation i
pathway to the child for each organ due to long term releases of radionuclides in gaseous effluents except noble gases-and tritiums.
a.
Enter the date on the form, b.
Enter the pathway.
j c.
Enter the release type, long or_ short.
d.
Enter the page as page 1.
e.
Enter each nuclide identified and the quantity released in pCi.
(If more than one.page is required, continue on succeeding pages and numberthemaccordingly.)
l l
_ l.
WP4.15
e e
f.
Enter the dose factors Mita-9 On each page used compute Mi Ta Qi for each organ and nuclide and then mi ta Qi for each organ, and enter on the form, i
h.
If more than one page was used, forward the organ totals calculated on the first page to the second, and compute the cumulative totals. Repeat for succeeding pages as required.
F F
C 2.
Using the form of Figure 3.11, calculate mi a Qi, where Mira = M ra +
t i
I M
V Mita + Mi ta for the food pathways to the child for cach organ due to long tenn releases of radionuclides in gaseous effluents except noble gases and triutium. Follow the procedure step number 1.
3.
Repeat steps 1 and 2 for short term releases.
4.
Repeat steps 1, 2 and 3 for the infant age group.
5.
Using the form of Figure 3.12, calculate the quantity MiTa Qi for the infant and child, long and short term releases, and inhalation and food path-ways for tritium releases.
6.
Using the form of Figure 3.13, calculate the. quantities M Ta Qi
}
and M ta 91
) for the grouna plane pathway dose resulting from long and short. releases.
7.
Using the form of Figure 3.14, calculate the organ doses due to long tenn releases of radionuclides in gaseous effluents except noble gases.
f l WP4.15 l
a.
Enter the date on the form, b.
Enter the release type, long or short.
c.
Enter the page.
X d.
Enter the value of Ii at the receptor location in the appropriate column.
Enter the values of ( ) and (') for the field in the appropriate e.
column.
M for the inhalation pathway for the f.
Enter the values of I Qi Mi Ta i
child and infant.
g.
Enter the quantity M Ta Qi ( ) calculated in steps 6 for long term releases.
F h.
Enter the value of E Qi Mi ra for the food pathways for the child i
and infant.
- i. Enter the values of QH3 NH ta calculated for the inhalation and 3
food pathways in step 5 for long term releases,
- j. Calculate the total dose to each organ due to long term releases for the child and infant age groups. The formula is presented at the bottom of the form of Figure 3.14.
8.
Repeat step 7 for short term releases if there were any and compute the total. doses by forwarding the long term doses and adding them to the short term doses. WP4.15
.~
Table 3.1 10 CFR PART 20 GASE0US RELEASES Infant 00se Factors Pj7 (inhalation) Pj r (milk)
=========================================================================
Orge; Nuclide Bone Liver Total Body Thyroid Kidney Lung GE-LLI H-3 0.0 6.47 + 2 6.47 + 2 6.47 + 2 6.47 + 2 6.47 + 2 6.47 + 2*
0.0 2.09 + 4 2.09 + 4 2.09 + 4 2.09 + 4 2.09 + 4 2.09 + 4 t
NA - 24 1.06 + 4 1.06 + 4 1.06 + 4 1.06 + 4 1.06 + 4 1.06 + 4 1.06 + 4 1.55 + 7 1.55 + 7 1.55 + 7 1.55 + 7 1.55 + 7 1.55 + 7 1.55 + 7 CR - 51 0.0 0.0 8.95 + 1 5.75 + 1 1.32 + 1 1.28 + 4 3.57 + 2 0.0 0.0 1.59 + 5 1.04 + 5 2.27 + 4 2.02 + 5 4.64 + 6 MN - 54 0.0 2.53 + 4 4.98 + 3 0.0 j4.98 + 3 1.00 + 6 7.06 + 3 0.0 3.83 + 7 8.69 + 6 0.0
-8. 50 + 6 0.0 1.41 + 7 FE - 59 1.36 + 4 2.35 + 4 9.48 + 3 0.0 0.0 1.02 + 6 2.48 + 4 2.21 + 8 3.87 + 8 1.52 + 8 0.0 0.0 1.14 + 8 1.85 + 8 CO - 57 0.0 6.51 + 2 6.41 + 2 0.0 0.0 3.79 + 5 4.86 + 3 0.0 8.80 + 6 1.43 + 7 0.0 0.0 0.0 3.00 + 7 CO - 58 0.0 1.22 + 3 1.82 + 3 0.0 0.0 7.77 + 5 1.11 + 4 0.0 2.39 + 7 5.97 + 7 0.0 0.0 0.0 5.96 + 7 CO - 60 0.0 8.02 + 3 1.18 + 4 0.0 0.0 4.51 + 6 3.19 + 4 0.0 8.66 + 7 2.04 + 8 0.0 0.0 0.0 2.06 + 8 ZN - 65 1.89 + 4 6.26 + 4 3.'11 + 4 0.0 3.25 + 4 6.47 + 5 5.14 + 4 5.46 + 9 1.87 +'10 8.63 + 9 0.0 9.08 + 9 0.0 1.58 + 10 SR - 89 3.98'+ 5 0.0 1.14 + 4 0.0' O.0 2.03 + 6 6.40 + 4 1.24 + 10 0.0 3.56 + 8 0.0 0.0 0.0 2.55 + 8
- First Line
- inhalation Second Line - milk WP4.15
Table 3.1 - (cont'd)
=========================================================================
Organ Nuclide Bone Liver Total Body Thyroid Kidney Lung GE-LLI SR - 90 4.09 + 7 0.0 2.59 + 6 0.0 0.0 1.12 + 7 1.31 + 5 1.19 + 11 0.0 3.04 + 10 0.0 0.0 0.0 1.49 + 9 SR - 91 9.56 + 1 0.0 3.46 0.0 0.0 5.26 + 4 7.34 + 4 2.70 + 5 0.0 9.77 + 3 0.0 0.0 0.0 3.20 + 5 SR - 92 1.05 + 1 0.0 3.91 - 1 0.0 0.0 2.38 + 4 1.40 + 5 4.75 0.0 1.77 - 1 0.0 0.0 0.0 5.13 + 1 Y - 91M 4.07 - 1 0.0 1.39 - 2 0.0 0.0 2.79 + 3 2.35 + 3 5.87 - 19 0.0 2.00 - 20 0.0 0.0 0.0 1.96 - 19 Y-91 5.88 + 5 0.0 1.57 + 4 0.0 05 0 2.45 + 6 7.03 + 4 7.22 + 4 0.0 1.92 + 3 0.0 0 :. 0 0.0 5.18 + 6 Y - 92 1.64 + 1 0.0 4.61 - 1 0.0 0.0 2.45 + 4 1.27 + 5 5.25 - 4 0.0 1.47 - 5 0.0 0.0 0.0 1.00 + 1 C"^
ZR - 95 1.15 + 5 2.79 + 4 2.03 + 4 0.0 3.11 + 4 1.75 + 6 2.17 + 4 6.74 + 3 1.64 + 3 1.16 + 3 0.0 1.77 + 3 0.0 8.17 + 5 NB - 95 1.57 + 4 6.43 + 3 3.78 + 3 0.0 4.72 + 3 4.79 + 5 1.27 + 4 5.86 + 5 2.41 + 5 1.40 + 5 0.0 1.73 + 5 0.0 2.04 + 8 MO - 9 9 0.0 1.65 + 2 3.23 + 1 0.0 2.65 + 2 1.35 + 3 4.87 + 4 0.0 2.07 + 8 4.04 + 7 0.0 3.10 + 8 0.0 6.83 + 7 TC - 99M 1.40 - 3 2.88 - 3 3.72 - 2 0.0 3.11 - 2 8.06 - 2 2.03 - 3 2.87 + 1 5.73 + 1 7.38 + 2 0.0 6.16 + 2 2.99 + 1 1.66 + 4 TC - 99 2.93 + 2 3.75 + 2 1.24 + 2 0.0 3.49 + 3 9.48 + 5 1.'09 + 4 2.16 + 8 2.95 + 8 9.19 + 7 0.0 2.49 + 9 2.87 + 7 1.27 + 9 WP4.15 a
Table 3.1 - (cont'd)
=========================================================================
Organ Nuclide Bone Liver Total Body Thyroid Kidney Lung GE-LLI RU - 103 2.02 + 3 0.0 6.79 + 2 0.0 4.24 + 3 5.52 + 5 1.61 + 4 8.57 + 3 0.0 2.87 + 3 0.0 1.78 + 4 0.0 1.04 + 5 RU - 106 8.68 + 4 0.0 1.09 + 4 0.0 1.07 + 5 1.16 + 7 1.64 +5 1.87 + 5 0.0 2.34 + 4 0.0 2.21 + 5 0.0 1.42 + 6 I - 131 3.79 + 4 4.44 + 4 1.96 + 4 1.48 + 7 5.18 + 4 0.0 1.06 + 3 2.70 + 9 3.18 + 9 1.40 + 9 1.05 + 12 3.72 + 9 0.0 1.14 + 8 l
I - 133 1.32 + 4 1.92 + 4 5.60 + 3 3.56 + 6 2.24 + 4 0.0 2.16 + 3 i
3.63 + 7 5.29 + 7 1.55 + 7 9.62 + 9 6.22 + 7 0.0 8.95 + 6 I - 135 3.86 + 6 7.60 + 3 2.77 + 3 6.96 + 5 8.47 + 3 0.0 1.83 + 3 1.09 + 5 2.18 + 5 7.94 + 4 1.'95 + 7 2.43 + 5 0.0 7.88 + 4 CS - 134 3.96 + 5 7.03 + 5 7.45 + 4 0.0 1.90 + 5 7.97 + 4 1.33 + 3 3.58 + 10 6.68 + 10 6.75 + 9 0.0 1.72 + 10 7.05 + 9 1.82 + 8 I
CS - 136 4.83 + 4 1.35 + 5 5.29 + 4 0.0 5.64 + 4 1.18 + 4 1.43 + 3 1.94 + 9 5.72 + 9 2.13 + 9 0.0 2.28 + 9 4.66 + 8 8.68 + 7 CS - 137 5.49 + 5 6.12 + 5 4.55 + 4 0.0 1.72 + 5 7.13 + 4 1.33 + 3 5.06 + 10 5.92 + 10 4.19 + 9 0.0 1.59 + 10 6.43 + 9 1.85 + 8 CS - 138 5.05 + 2 7.81 + 2 3.98 + 2 0.0 4.10 + 2 6.54 + 1 8.76 + 2 8.98 - 23 1.46 - 22 7.08 - 23 0.0 7.28 - 33 1.14 - 23 2.33 - 23 BA - 140 5.60 + 4 5.60 +'l 2.90 + 3 0.0 1.34 + 1 1.60 + 6 3.84 + 4 2.39 + 8 2.39 + 5 1.23 + 7 0.0 5.68 + 4 1.47 + 5 5.87 + 7 l
LA - 140 5.05 + 2 2.00 + 2 5.15 + 1 0.0 0.0 1.68 + 5 8.48 + 4 4.07 + 1 1.60 + 1 4.12 0.0 0.0 0.0 1.88 + 5 WP4.15 r
Table 3.1 - (cont'd)
=========================================================================
Organ Nuclide Bone Liver Total Body Thyroid Kidney Lung GE-LLI CE - 141 2.77 + 4 1.64 + 4 1.99 + 3 0.0 5.26 + 3 5.17 + 5 2.16 + 4 4.28 + 4 2.61.+ 4 3.07 + 3 0.0 8.05 + 3-0.0 1.35 + 7 CE - 144 3.19 + 6 1.21 + 6 1.76 + 5 0.0 5.38 + 5 9.84 + 6 1.48 + 5 2.29 + 6 9.36 + 5 1.28.+ 5 0.0 3.78 + 5 0.0 1.31 + 8 NP - 239 3.71 + 2 3.32 + 1 1.88 + 1 0.0 6.62 + 1 5.95 + 4 2.49 + 4 3.63 + 1 3.25 1.83 0.0 5.47 0.0 9.38 + 4 1
Y k WP4.15
,e i
TABLE 3.2 L
t ATNSPHERIC OISPERSION CONSTANTS t
One Stack Blower Operation 1
(
)
L gf (
)
=
i i
(
)
i
=
(
)
h) 9-(
)
=
(
)
(
)
1 b
4
(
- ) -
- d) q
(
) _
~
)
(.-
)
=
h) l q
.(.
.)
=
Determined by actual meteorology.'
t i
[
F '
- WP4.15
,4-m
.d,,w,g eA
....a 3
,,r->
s--
- m ev
+ v e s -- w w - --- - - *es$*
---vn e
w e e 4.
er - --
vb
IE l
'~,;
TABLE 3.2 - (cont'd)
ATM) SPHERIC DISPERSION CONSTANTS Two stack-Blower Operation
(
)=
(
)
- (
)
=
(
)
=
(
)
. e) 4
(
)
(
)
(
)=
Ef (
4
)
(
). "
'(
) '"
i a)
- )
q
(
Det'ennined by actual meteorology.-
l-WP4.15 P
l er-e v
ve-e-
4 y
y e
t r--
+- -
f.
. s s
\\.
- ' s.- W @';-p g y-s
., ~
y-
--s s-
-- g-. /
4', g *.
Table 3.3 f
\\. - -
sv s
EXTERNAL DOSE FACTORS FOR STANDING ON CONTAHINARD GROUND
\\/-
(mr'em/hr r,er pCi/m2)
N
'V A
g F
\\
7
. ~ - -
~
Element Total Body _
giny, f -;i s
,l
, - w --
H-3 0.0
. 0.0' 1<
C-14 0.0
' -G.0, NA-24 2.50E-08 O 2.90E-08. '
i P-32 0.0 0.0 Cr-51 2.20E-10 %+-
2.60E-10 Mn-54 5.80E-09 6.80E-09 Mn-56 1.10E-08
'~1.30E-08 t'
\\
Fe-55 0.0 0.0 0
Co-58 7.00E-09 8.20E-09 1+.'
' ,, N Fe-59 8.00E-09 9.40E-09
'. N Co-60 1.70E-08 2.00E-08 Ni 63 0.0 0.0 t'
Nr-65 3.70E-09 4.30E-W9 Cu-64 1.50E-09
- 1. 70E-09 ' ',,_-
p' Zn-65 4.00E-09 4.01E-09'
/
Zn-69 0.0 0.7 '-
"f 1
Br-83 6.40E-11 9:30E-)I 1
. ~r Br-84 1.20E-08 1.eE-08' 0.0 ' /
Br-85 0.9 s
- 4.10E-10 w' \\ - 7.*JCr10 ' M '
Rb-86
9.60E-09
'4.00E 09 Rb-88
^-
S d
M 0E-08
"'s-1.80E-08 Rb-89
- 5.60E-13 6.50E-13 T
Sr-89 7.10E-09
^ \\ '
Sr-91
' " ~ ' '
8.30E-09
\\
^~
Sr-92 9.00E-09 l.00E-06,
- s' Y-90 N
2.20b12 2:60E-12
+'
s "'
I WE 09
~y, 4.40E-09 t%
s Y-91M o
'Y
--240E11 Y 91 2.70E-11).> 7,.,
s Y-92 1.60E n9 D'
1.9UE-09
~'
,% s s
Y-93 5.70E-10 e'
7.80E-10
^
(%
N' s
Zr-95 5.00E-09 5.80E-09 v
Zr-97 5.50E-09 6.40E-09
- \\
^ '
%]*
No-95 5.10E-09
~
,6.00E-09 Mo-99 1.90E-09 2.20E-09 Tc-99M 9.60E-10 1.10E-09 s
r,,
Tc-101 2.70E-09
'w 3.00E-09
.t
~'
I Ru-103 3.6hC-09 4'. 20E-09
~
Ru-105 4.50E-09 5)0E-09 k
Ru-106 1.50E+09 s w*
l.80E-09 ', 1
-t Ag-110M 1.800- F D'%g
%
- 7.
.'+
~
2.10E-08 5
~Te-125M 3.50E-114 4.00E-11
,\\ N ' s '
k Te-127M 1.10E-12' 1.3W-12 Te-127 1.00E-11
- 1.10E-11 N
\\
' k [N Te-129M 7.70E-10 79.00E-10'
'M\\
Te-129 7.10E-10
/.
V 8;40E-10
- b* %
Te-131M 8.40E-09 eT f 9.90Cc00
,e
"\\
' 2.60E-06',. Y ' # '
Te-131 2.20E 07. ;,,-
Te-132 1.70E-09 t^
s 2.00C -09 m
I-130 1.40E-08 1.70E-08 M.. N t
l-131
.P.sw-09
,\\M 2:00f=a* A*'-
~
3.407-I-132 1./0C;08 %
3%
1-133.
/3.70E-09 L
'l,A 40E-09:
.I ^ ' % '
I-134 1.%f-08.-. -
1.90E-08
'~
s I-135 3
1.20608-1.40E=08
?
a
.+
- % Q#
s
.w s-S og..
40 -
v W '-
- 'j w
.q)f'-
WP4.15 s-4 s
- "%a ws ' %g;g!,j. % 7*y's.
t 1
- s q - E-n
D Table 3.3 - (cont'd)
Element Total Body Skin Cs-134 1.20E-08 1.40E-08 Cs-136 1.50E-08 1.70E-08 Cs-137 4.20E-09 4.90E-09 Cs-138 2.10E-08 2.40E-08 Ba-139 2.40E-09 2.70E-09 Ba-140 2.10E-09 2.40E-09 ga-141 4.30E-09 4.90E-09 Ba-142 7.90E-09 9.00E-09 La-140 1.50E-08 1.70E-08 La-142 1.50E-08 1.80E-08 Ce-141 5.50E-10 6.20E-10 Ce-143 2.20E-09 2.50E-09 Ce-144 3.20E-10 3.70E-10 Pr-143 0.0 0.0 Pr-144 2.00E-10 2.30E-10 Nd-147 1.00E-09 1.20E-09 W.187 3.10E-09 3.60E-09 Np-239 9.50E-10 1.10E-09 M
V
=
%F f.
tr y 5
4 41 -
WP4.15
Table 3.4 10 CFR PART 50 GASEQUS RELEASES Child Dose Factors Mj7 (inhalation) Mj,(food)
=========================================================================
Organ Nuclide Bone Liver Total Body Thyroid Kidney Lung GE-LLI H-3 0.0 1.12 + 3 1.12 + 3 1.12 + 3 1.12 + 3 1.12 + 3 1.12 + 3*
0.0 5.09 + 4 5.09 + 4 5.09 + 4 5.09 + 4 5.0 9 + 4 5.09 + 4 NA - 24 1.61 + 4 1.61 + 4 1.61 + 4 1.61 + 4 1.61 + 4
- 1. 61 + 4 1.61 + 4 4.82 + 6 4.82 + 6 4.82 + 6 4.82 + 6 4.82 + 6 4.82 + 6 4.82 + 6 CR - 51 0.0 0.0 1.54 + 2 8.55 + 1 2.43 + 1 1.70 + 4 1.08 + 3 0.0 0.0 1.72 + 5 9.57 + 4 2.61 + 4 1.75 + 5 9.14 + 6 MN - 54 0.0 4.29 + 4 9.51 + 3 0.0 1.00 + 4 1.58 + 6 2.29 + 4 0.0 6.72 + 8 1.79 + 8 0.0 1.88 + 8 0.0 5.64 + 8 FE - 59 2.07 + 4 3.34 + 4 1.67 + 4 0.0 0.0 1.27 + 6 7.07 + 4 6.58 + 8 1.06 + 9 5.30 + 8 0.0 0.0 3.09 + 8 1.11 + 9 CO - 57 0.0 9.03 + 2 1.07 + 3 0.0 0.0 5.07 + 5 1.32 + 4 0.0 3.55 + 7 7.18 + 7 0.0 0.0 0.0 2.91 + 8 CO - 58 0.0 1.77 + 3 3.16 + 3 0.0 0.0 1.11 + 6 3.44 + 4 0.0 7.99 + 7 2.45 + 8 0.0 0.0 0.0 4.66 + 8 CO - 60 0.0 1.31 + 4 2.26 + 4 0.0 0.0 7.07 + 6 9.62 + 4 0.0 4.46 + 8 1.31 + 9 0.0 0.0 0.0 2.47 + 9 ZN - 65 4.26 + 4 1.13 + 5 7.03 + 4 0.0 7.14 + 4 9.95 + 5 1.63 + 4 3.62 + 9 9.63 + 9 5.99 + 9 0.0 6.07 + 9 0.0 1.69 + 9 SR - 89 5.99 + 5 0.0 1.72 + 4 0.0 0.0 2.16 + 6 1.67 + 5 3.93 + 10 0.0 1.12 + 9 0.0 0.0 0.0 1.52 + 9
- First Line
- inhalation Second Line - food WP4.15
Table 3.4 - (cont'd)
==========================================================================
Organ Nuclide Bone Liver Total Body Thyroid Kidney Lung GE-LLI SR - 90 1.01 + 8 0.0 6.44 + 6 0.0 0.0 1.48 + 7 3.43 + 5 1.30 + 12 0.0 3.30 + 11 0.0 0.0 0.0 1.75 + 10 SR - 91 1.21 + 2 0.0 4.59 0.0 0.0 5.33 + 4 1.74 + 5 5.85 + 5 0.0 2.21 + 4 0.0 0.0 0.0 1.29 + 6 SR - 92 1.31 + 1 0.0 5.25 - 1 0.0 0.0 2.40 + 4 2.42 + 5 7.33 + 2 0.0 2.94 + 1 0.0 0.0 0.0 1.39 + 4 Y-91M 5.07 - 1 0.0 1.84 - 2 0.0 0.0 2.81 + 3 1.72 + 3 8.85 - 9 0.0 3.22 - 10 0.0 0.0 0.0 1.73 - 5 Y-91 9.14 + 5 0.0 2.44 + 4 0.0 0.0 2.63 + 6 1.84 + 5 1.94 + 7 0.0 5.19 + 5 0.0 0.0 0.0 2.59 + 9 Y - 92 2.04 + 1 0.0 5.81 - 1 0.0 0.0 2.39 + 4 2.39 + 5 1.55 0.0 4.52 - 2 0.0 0.0 0.0 4.49 + 4 ZR 95 1.90 + 5 4.18 + 4 3.70 + 4 0.0 5.96 + 4 2.23 + 6 6.11 + 4 5.37 + 6 1.18 + 6 1/05 + 6 0.0 1.69 + 6 0.0 1.23 + 9 NB - 95 2.35 + 4 9.18 + 3 6.55 + 3 0.0 8.62 + 3 6.14 + 5 3.70 + 4 6.03 + 5 2.35 + 5 1.68 + 5 0.0 2.21 + 5 0.0 4.34 + 5 MO - 99 0.0 1.72 + 2 4.26 + 1 0.0 3.92 + 2 1.35 + 5 1.27 + 5 0.0 4.83 + 7 1.19 + 7 0.0 1.03 + 8 0.0 3.99 + 7 TC - 99M 1.78 - 3 3.48 - 3 5.77 - 2 0.0 5.07 - 2 9.51 + 2 4.81 + 3 1.14 + 1 2.23 + 2 3.69.+ 2 0.0 3.23 + 2 1.13 + 1 1.27 + 4 TC - 99 4.96 + 2 5.51 + 2 1.98 + 2 0.0 6.48 + 3 1.25 + 6 2.87 + 4 2.57 + 8 2.86 + 8 1.03 + 8 0.0 3.37 4 9 2.53 + 8 3.00 + 9 WP4.15
.o Table 3.4 - (cont'd)
==========================================================================
Organ Nuclide Bone Liver Total Body Thyroid Kidney Lung GE-LLI RU - 103 2.79 + 3 0.0 1.07 + 3 0.0 7.03 + 3 6.62 + 5 4.48 + 4 9.76 + 7 0.0 3.75 + 7 0.0 2.46 + 8 0.0 2.52 + 9 RU - 106 1.36 + 5 0.0 1.69 + 4-0.0 1.84 + 5 1.43 + 7 4.29 + 5 3.56 + 9 0.0 4.44 + 8 0.0 4. 81 + 9 0.0 5.54 + 10 I - 131 4.81 + 4 4.81 + 4 2.73 + 4 1.62 + 7 7.88 + 4 0.0 2.84 + 3 7.98 + 8 8.02 + 8 4.56 + 8 2.'65 + 11 1.32 + 9 0.0 7.14 + 7 I - 133 1.66 + 4 2.03 + 4 7.70 + 3 3.85 + 6 3.38 + 4 0.0 5.48 + 3 1.21 + 7 1.50 + 7 5.67 + 6 2.78 + 9 2.50 + 7 0.0 6.04 + 6 I - 135 4.92 + 3 8.73 + 3 4.14 + 3 7.92 + 5 1.34 + 4 0.0 4.44 + 3 8.76 + 4 1.58 + 5 7.46 + 4 1.40 + 7 2.42 + 5 0.0 1.20 + 5 CS - 134 6.51 + 5 1.01 + 6 2.25 + 5 0.0
-3. 3 0 + 5 1.21 + 5 3.85 + 3 3.11 + 10 5.10 + 10 1.08 + 10 0.0 1.58 + 10 5.67 + 9 2.75 + 8 CS - 136 6.51 + 4 1.71 + 5 1.16 + 5 0.0 9.55 + 4 1.45 + 4 4.18 + 3 5.87 + 8 1.61 + 9 1.04 + 9 0.0 8.59 + 8 1.28 + 8 5.67 + 7 CS - 137 9.07 + 5 8.25 + 5 1.28 + 5 0.0 2.82 + 5 1.04 + 5 3.62 + 3 4.57 + 10 4.38 + 10 6.46 + 9 0.0 1.43 + 10 5.13 + 9 2.74 + 8 CS - 138 6.33 + 2 8.40 + 2 5.55 + 2 0.0 6.22 + 2 6.81 + 1 2.70 + 2 6.56 - 11 9.12 - 11 5.78 - 11 0.0 6.41 - 11 6.90 - 12 4.20 - 11 BA - 140 7.40 + 4 6.48 + 1 4.33 + 3 0.0 2.11 + 1 1.74 + 6 1.02 + 5 3.55 + 8 3.11 + 5 2.07 + 7 0.0 1.01 + 5 1.85 + 5 1.80 + 8 LA - 140 6.44 + 2 2.25 + 2 7.55 + 1 0.0 0.0 1.83 + 5 2.26 + 5 3.26 + 3 1.14 + 3 3.84 + 2 0.0 0.0 0.0 3.18 + 7 WP4.15
7 Table 3.4 - (cont'd) l l
l
==========================================================================
Organ Nuclide Bone Liver Total Body Thyroid Kidney Lung GE-LLI CE - 141 3.92 + 4 1.95 + 4 2.90 + 3 0.0 8.55 + 3 5.44 + 5 5.66 + 4 6.71 + 5 3.35 + 5 4.97 + 4 0.0 1.47 + 5 0.0 4.17 + 8
,CE -'144 6.77 + 6 2.12 + 6 3.61 + 5 0.0 1.17 + 6 1.20 + 7 3.89 + 5 1.27 + 8 3.99 + 7 6.80 + 6 0.0 2.21 + 7 0.0 1.04 + 10 NP - 239 4.66 + 2-3.34 + 1 2.35 + 1 0.0 9.73 + 1 5.81 + 4 6.40 + 4 I
2.55 + 3 1.83 + 2 1.29 + 2 0.0 5.30 + 2 0.0 1.36 + 7 1
! WP4.15
Table 3.5 10 CFR PART 50 GASEQUS RELEASES Infant Dose Factors Mj7 (inhalation) Pjr (food)
==========================================================================
Organ Nuclide Bone Liver Total Body Thyroid Kidney Lung GE-LLI H-3 0.0 6.47 + 2 6.47 + 2 6.47 + 2 6.47 + 2 6.47 + 2 6.47 + 2*
0.0 2.09 + 4 2.09 + 4 2.09 + 4 2.09 + 4 2.09 + 4 2.09 + 4 NA - 24 1.06 + 4 1/06 + 4 1.06 + 4 1.06 + 4 1.06 + 4 1.06 + 4 1.06 + 4 7.74 + 6 7.74 + 6 7.74 + 6 7.74 + 6 7.74 + 6 7.74 + 6 7.74 + 6 CR - 51 0.0 0.0 8.95 + 1 5.75 + 1 1.32 + 1 1.28 + 4 3.57 + 2 0.0 0.0 8.26 + 4 5.39 + 4 1.18 + 4 1.05 + 5 2.41 + 6 MN - 54 0.0 2.53 + 4 4.98 + 3 0.0 4.98 + 3 1.00 + 6 7.06 + 3 0.0 2.47 + 7 5.59 + 6 0.0 5.47 + 6 0.0 9.06 + 6 FE - 59 1.36 + 4 2.35 + 4 9.4 8 + 3 0.0 0.0 1.02 + 6 2.48 + 4 1.20 + 8 2.10 + 8 8.27 + 7 0.0 0.0 6.21 + 7 1.00 + 8 CO - 57 0.0 6.51 + 2 6.41 + 2 0.0 0.0 3.79 + 5 4.86 + 3 0.0 5.62 + 6 9.14 + 6 0.0 0.0 0.0 1.92 + 7 CO - 58 0.0 1.22 + 3 1.82 + 3 0.0 0.0 7.77 + 5 1.11 + 4 0.0 1.37 + 7 3.42 + 7 0.0 0.0 0.0 3.41 + 7 CO - 60 0.0 8.02 + 3 1.18 + 4 0.0 0.0 4.51 + 6 3.19 + 4 0.0 5.80 + 7 1.37 + 8 0.0 0.0 0.0 1.38 + 8 ZN - 65 1.89 + 4 6.26 + 4 3.11 + 4 0.0 3.25 + 4 6.47 + 5 5.14 + 4 3.47 + 9 1.19 + 10 5.49 + 9 0.0 5.77 + 9 0.0 1.00 + 10 SR - 89 3.98 + 5 0.0 1.14 + 4 0.0 0.0 2.03 + 6 6.40 + 4 6.84 + 9 0.0 1.96 + 8 0.0 0.0 0.0 1.41 + 8
- First Line
- inhalation Second Line - food --
WP4.15
- - - - ~ ~
Table 3.5 - (cont'd)
==========================================================================
Organ Nuclide Bone Liver Total Body Thyroid Kidney Lung GE-LLI SR - 90 4.09 + 7 0.0~
2.59 + 6 0.0 0.0 1.12 + 7 1.31 + 5 8.05 + 10 0.0 2.05 + 10 0.0-0.0 0.0 1.01 + 9 SR - 91 9.56 + 1 0.0 3.46 0.0 0.0 5.26 + 4 7.34 + 4 1.34 + 5 0.0 4.87 + 3 0.0 0.0 0.0 1.59 + 5 SR - 92 1.05 + 1 0.0 3.91 - 1 0.0 0.0 2.38 + 4 1.40 + 5 2.34 0.0 8.70 - 2 0.0 0.0 0.0 2.53 + 1 Y - 91M 4.07 - 1 0.0 1.39 - 2 0.0 0.0 2.79 + 3 2.35 + 3 2.80 - 19 0.0 9.54 - 21 0.0 0.0 0.0 9.34 - 16 Y - 91 5.88 + 5 0.0 1.57 + 4 0.0 0.0 2.45 + 6 7.03 + 4 4.05 + 4 0.0 1.08 + 3 0.0 0.0 0.0 2.90 + 6 Y-92 1.64 + 1 0.0 4.61 - 1 0.0 0.0 2.45 + 4 1.27 + 5 2.59 - 4 0.0 7.29 - 6 0.0 0.0 0.0 4.95 ZR - 95 1.15 + 5 2.79 + 4 2.03 + 4 0.0 3.11 + 4 1.75 + 6 2.17 + 4 3.82 + 3 9.31 + 2 6.61 + 2 0.0 1.00 + 3 0.0 4.64 + 5 NB - 95 1,57 + 4 6.43 + 3 3.78 + 3 0.0 4.72 + 3 4.79 + 5 1.27 + 4 3.10 + 5 1.28 + 5 7.39 + 4 0.0 9.16 + 4 0.0 1.08 + 8 MO - 99 0.0 1.65 + g-3.23 + 1 0.0 2.65 + 2 1.35 + 3 4.87 + 4 0.0 1.04 + 8 2.02 + 7 0.0 1.55 + 8 0.0 3.41 + 7 TC - 99M 1.40 - 3 2.88 - 3 3.72 - 2 0.0 3.11 - 2 8.06 - 2 2.03 - 3 1.38 + 1 2.85 + 1 3.66 + 2 0.0 3.06 + 2 1.49 + 1 8.26 + 3 TC - 99 2.93 + 2 3.75 + 2 1.24 + 2 0.0 3.49 + 3 9.48 + 5 1.09 + 4 1.47 + 8 1.99 + 8 6.21 + 7 0.0 1.68 + 9 1.34 + 7 8.61 + 8 WP4.15
3
- o Table 3.5 - (cont'd)
====-=====================================================================
organ Nuclide Bone Liver Total Body Thyroid Kidney Lung GE-LLI RU - 103 2.02 + 3 0.0 6.79 + 2 0.0 4.24 + 3 5.52 + 5 1.61 + 4 4.60 + 3 0.0 1.54 + 3 0.0 9.57 + 3 0.0 5.59 + 4 RU - 106 8.68 + 4 0.0 1.09 + 4 0.0 1.07 + 5 1.16 + 7 1.64 + 5 1.21 + 5 0.0 1.51 + 4 0.0 1.43 + 5 0.0 9.20 + 5 I - 131 3.79 + 4 4.44 + 4 1.96 + 4 1.48 + 7 5.18 + 4 0.0 1.06 + 3 1.35 + 9 1.59 + 9 7.00 + 8 5.23 + 11 1.86 + 9 0.0 5.68 + 7 I-133 1.32 + 4 1.92 + 4 5.60 + 3 3.56 + 6 2.24 + 4 0.0 2.16 + 3 1.81 + 7 2.64 + 7 7.73 + 6 4.P0 + 9 3.10 + 7 0.0 4.47 + 6 I - 135 3.86 + 6 7.60 + 3 2.77 + 3 6.96 + 5 8.47 + 3 0.0 1.83 + 3 5.44 + 4 1.08 + 5 3.94 + 4 9.70 + 6 1.21 + 5 0.0 3.92 + 4 CS - 134 3.96 + 5 7.03 + 5 7.45 + 4 0.0 1.90 + 5 7.97 + 4 1.33 + 3 2.37 + 10 4.42 + 10 4.46 + 9 0.0 1.14 + 10 4.66 + 9 1.20 + 8 CS - 136 4.83 + 4 1.35 + 5 5.29 + 4 0.0 5.64 + 4 1.18 + 4 1.43 + 3 9.75 + 8 2.87 + 9 1.07 + 9 0.0 1.14 + 9 2.34 + 8 4.35 + 7 CS - 137 5.49 + 5 6.12 + 5 4.55 + 4 0.0 1.72 + 5 7.13 + 4 1.33 + 3 3.41 + 10 3.99 + 10 2.83 + 9 0.0 1.07 + 10 4.33 + 9 1.25 + 8 CS - 138 5.05 + 2 7.81 + 2 3.98 + 2 0.0 4.10 + 2 6.54 + 1 8.76 + 2 4.,18 - 23 6.80 - 23 3.29 - 23 0.0 3.39 - 23 5.29 - 24 1.09 - 22 BA - 140 5.60 + 4 5.60 + 1 2.90 + 3 0.0 1.34 + 1 1.60 + 6 3.84 + 4 1.20 + 8 1.20 + 5 6.18 + 6 0.0 2.85 + 4 7.36 + 4 2.94 + 7 LA - 140 5.05 + 2 2.00 + 2 5.15 + 1 0.0 0.0 1.68 + 5 8.48 + 4 2.03 + 1 8.01 2.06 0.0 0.0 0.0 9.41 + 4
~
~
WP4.15
Table 3.5 - (cont'd)
==========================================================================
Organ
-Nuclide Bone Liver Total Body Thyroid Kidney Lung GE-LLI CE - 141 2.77 + 4 1.64 + 4 1.99 + 3 0.0
'5.26 + 3 5.17 + 5 2.16 + 4 2.25 + 4 1.37 + 4 1.62 + 3 0.0 4.23 + 3 0.0 7.09 + 6 CE - 144 3.19 + 6 1.21 + 6 1.76 + 5 0.0 5.38 + 5 9.84 + 6 1.48 + 5 1.46 + 6 5.99 + 5 8.20 + 4 0.0 2.42 + 5 0.0 8.40 + 7 NP - 239 3.71 + 2 3.32 + 1 1.88 + 1 0.0 6.62 + 1 5.95 + 4 2.49 + 4 1.81 + 1 1.62 9.16 - 1 0.0 3.23 0.0 4.69 + 4
~ 49 ~
WP4.15
.~
Figure 3.1 10 CFR PART 20 GASEQUS RELEASES NOB'.E GASES Date Nuclide i Release Rate, Qj.
RNGi 0FBj DF[
OFSj 135Xe 1.81 E-03 1.92 E-03 1.86 E-03 133Xe 2.94 E-04 3.53 E-04 3.06 E-04 l
88 r 1.47 E-02 1.52 E-02 2.37 E-03 K
85mKr 1.17 E-03 1.23 E-03 1.46 E-03 87 r 5.92 E-03 6.17 E-03 9.73 E-03 1
K
.138 e 8.83 E-03 9.21 E-03 4.13 E-03 X
135mXe 3.12 E-03 3.36 E-03 7.11 E-04 133mXe 2.51 E-04 3.27 E-04 9.94 E-04 l
131mXe 9.15 E-05 1.56 E-04 4.76 E-04 137Xe 1.42 E-03 1.51 E-03 1.22 E-02 85Kr 1.61 E-05 1.72 E-05 1.34 E-03 1
41 r 8.84 E-03 9.30 E-03 2.69 E-03 A
l l
l 1i*
- Rem-m3 mrad-m3 m
pCi-yr pCi-y r.
WP4.15
1
)
j S
F
=
D
)
(
j S
)
F i
G D
(
N R
)
(
i e
G N
t R
a
(
D f
)
S
[
E F
S D
=
A
(
)
E
[
L
)
F E
i R
G O
(
N S
R US
(
)
2 i
QE 3
ES G
SA N
e AG R
1
(
5 r
G u
E g
0L f
i 2B F
O TN RA P
R F
C
)
f 0
F 1
D
(
=
)
)
f ig F
g D
(
R
(
)
i G
N R
(
f 1
,e e
e e
d e
e r
e X
X X
e i
X X
r K
r X
m m
m X
r r
l 5
3 K
m K
8 5
3 1
7 K
A c
3 3
8 5
7 3
3 3
3 3
5 1
u 1
1 8
8 8
1 1
1 1
1 8
4 N
5 1
4 PW
1 Figure 3.3 l
10 CFR 20 GASEQUS RELEASES NOBLE GASES A'. ARM SETPOINT CA'.CULATIONS (10)(f)i(RNGj)(DFBj)(FR) 6 TBF =
(1.11x10)(f)i(RNGj)(DFf)(FR) 6 SFG =
(10 ) (1) i (RNGi) (DFSj) (FR) 6 SFB =
q 6.0 x 10- 5 sec/m3
=
(FR) = 1 blower operation = 1.6 50 x 107 cc/sec 2 blower operation = 3.304 x 107 cc/sec TBF mrem - cc
=
pCi - yr SFG =-
mrad - cc pCi - yr SFB mrem - cc
=
pCi - yr h
500 mrem /yr pCi/cc
=
=
TBF h
3000 mrem /yr pCi/cc
=
=
(SFG + SFB)-
1.ower value of h pCi/cc
=
(SPING Channel 05 Alarm Set Point) -WP4.15
Figure 3.4 10 CFR 20 GASE0US RELEASES PARTICULATE DOSES Date Eit (inhalation)'(mrem /pCi)
Nuclide i QPi RPi T. Body GI-Tract Bone Liver Ki dney Tnyroid Lung 3H 4.62E-07 4.62E-07 NO DATA 4.62E-07 4.62E-07 4.62E-07 4.62E-07 131I 1.40E-05
- 7. 56E-07 2.71E-05 3.17E-05 3.70E-05 1.06E-02 NO DATA 133I 4.00E-06 1.54E-06 9.46E-06 1.37E-05 1.60E-05 2.54E-03 N) D A,T A, 140Ba 2.07E-06 2.74E-05 4.00E-05 4.00E-08 9.59E-09 NO DATA 1.14E-03 140La 4.68E-08 6.06E-05 3.61E-07 1.43E-07 NO DATA NO DATA 1.20E-04 60Co 8.41E-06 2.28E-05 NO DATA 5.73E-06 N) DATA N) DATA 3.22E-03 137Cs 3.2SE-05 9.53E-07 3.92E-04 4.17E-04 1.23E-04 N) DATA 5.09E-05 51Cr 6.30E-08 2.55E-07 NO DATA NO DATA 9.4 5E-09 4.11E-08 9.17E-06 13"Cs
- 5. 32E-05 9.53E-07 2.83E-04 5.02E-04 1.36E-04 NO DATA 5.69E-0 5 106Ru(Rh) 7.77E-06 1.17E-04 6.20E-05 N) DATA 7.61E-05 NO DATA ' 8.26E-03 90Sr 1.8 5E-03 9.36E-05 2.92E-02 NO DATA NO DATA N) DATA 8.03E-03 95Zr 1.4 5E-05 1.55E-05 8.24E-05 1.99E-05 2.22E-05 NO DATA 1.25E-03 65Zn 2.22E-05 3.67E-05 1.38E-05 4.47E-05 2.32E-05 NO DATA 4.62E-04 54Mn 3.56E-06 5.04E-06 NO DATA 1.81E-05 3.56E-06 NO DATA 7.14E-04 144Ce 1.26E-04 1.06E-04 2.28E-03 8.65E-04 3.84E-04 NO DATA 7.03E-03 141Ce 1.42E-06 1.54E-05 1.98E-05 1.19E-05
- 3. 7 5E-06 NO DATA 3.69E-04 Ehpi=DP=
1
- Used for calculating instrument setpoints. WP4.15
l
,l1I 1
I l
n i
k S
gnu L
e ta D
d iory h
T yen d
)
i S
d K
E o
S o
A f
E
(
LS EE r
RS j
r 5
O P
e SD v
3 U
i QE L
e ET 4
r SA 5
u AL g
GU i
C F
0I 2T e
R n
RA o
FP B
C 0
1 tcar T
I G
y do B
T
)
i h
R e
(
d aao3 rsurrnnee B%o7C c C C%0SZZMCc i
} [
I 4
5 s4 4 I 1 3 0
lc 3 3 4 4 s3 S 3 0 9 9 s5 4 4 1 1 1 1 1
1 1 1 1 u
N 5
1 4
PW l
!l 1
l n
i k
S gnu l
e ta D
d iory h
T
)
y e
e n
n a
d l
i S
p K
E S
d A
n E
u LS o
EE r
RS g
r 6
O
(
e SD v
3 U
7 i
0E j
L e
ET P
5 r
SA 5
u AL g
GU i
C F
0I 2T e
R n
RA o
FP B
C 0
1 tcar T
I G
y do B
T
)
i h
R e
(
d aaoS rS uprnnee BLgCCCR3ZZMCC i
H
[ {
3 1 3 0 0 0 7 I 4 6 0 5 5 " 4 1 lc 3 3 4 4 63 S 3 0 9 96 5 4 4 u
1 1 1 1 1
1 1 1 1 N
5 1
4 PW I
j; lll 1l I1i
ll l
]
)ena lp dnuorg
(
r j
P
[
e t
g a
p D
R
]
)
doo f
(
S r
E j
S P
A
[
ELS j
EE p
RS R
7 O
SD 3
U0E e
e ET s
r SA u
AL g
GU i
C
]
F 0I
)
2T n
R o
RA i
FP t
C a
l 0
a 1
hn i
(
7 j
P
[
s t
j p
n i
R op tes gn i
ta
)
l i
h u
R c
e
(
l d
aao5 rsurrnnee a
BLCcCCRSZZMCC c
i H] g l
'1 3 0 0 0 71 4 6 0 s5 4 4 1 c
3 3 4 4 63 53 0 9 s65 4 4 r
u 1 1 1 1 1
1 1 1 1 o
N f
T d
n e
5 a
s 1
g U
r 4
P O
W
- l l
4 9
- 1 1
)ena lp
.rg (r
i P
ip R
)
Ei e
ta D
(
)
@Q
)
doo f
( t i
S P
E i
S p
A R
ELS
)
EE RS Ei 8
O SD 3
U OE e
ET 7
r SA 5
u AL g
GU i
C F
0I
(
)
2T R
0
)
1 la hn i
(r i
Pr i
p R
s tn
)e3 i
e m
o Ii p
s 5
t e
0 s
1x g
n 0
i sr 6
ta e
(
w l
o u
)
Nq c
l l
B a
f c
o
)
T I
h r
r R
o e
n e
(
f 5
b a
d a,osrsurrnnee 1
m g
i g1 1 B g C C C Ck0ShhY4CC d
u r
l 3 1 3 0 0 0 7 I 4 1
e 4
3 3 4 4 63 S 3 0 9 9 6S 4 4 s
P N
O cu 1 1 1 1 1
1 1 1 1 U
W N
l Figure 3.9 10 CFR 20 GASEOUS RELEASES 3, 131, 133I PARTICULATE 11 1
ALARM SET POINT CALCULATIONS Date 1500 mrem /yr Qpt
=
It [ Pit (1 alation) x Rpg] x Y x 100 pCi q
VCi pCi/sec QPt
=
Organ T (from Figures 3.8)
Qpr (pCi/sec)
T. Body GI-LLI Bone Liver Kidney Lung Skin Thyroid One Blower Operation Two Blower Operation hp r Lowest 9P_T x dF Lowest 9Pt x dF Qp y
=
=
FR 3.304x10 ' cc/see where:
Qpr = LCi/sec
LCi/sec x _________cc FR = 1.650 x 107 cc/sec 3.304 x 10 ' cc/sec dF = total flow through sample media QPt pCi
=
_________ICi/sec x __________cc 1.650 x 10 ' cc/sec.
(SPING Channel 01 or 03 Alarm Set Point.)
- QP t HCI
-(SPING Channel 01 or 03 Alarm Set Point.)
- WP4.15
Fiaure 3.10 10 CFR 50 GASE0US RELEASES Date NOB'.E GAS DOSES (r,0) sec/m3 (1) (r,0) q sec/m3 Nuclide DFY OFS Qj OFY Qj DFS Qj gj OFY gj OF6 gj i
i i
i i
i j
135Xe 1.92 E-03 1.81 E-03
~13 3Xe 3.53 E-04 2.94 E-04 J
88Kr 1.52 E-02 1.47 E-02
{
82Kr 1.23 E-03 1.17 E-03 87Kr 6.17 E-03 5.92 E-03 138Xe 9.21 E-03 8.83 E-03 13mXe 3.36 E-03 3.12 E-03 13 nXe 3.27 E-04 2.51 E-04 131mXe 1.56 E-04 9.15 E-05 137Xe 1.51 E-03 1.42 E-03 85Kr 1.72 E-05 1.61 E-05 41Ar 9.30 E-03 8.84 E-03 l
l I
l I
I 0
X D (x)(r,0)i DY(r,0) = 3.17x10-2 [ (q) (r,0) imFY Qj
+
q IDFY gj ]
mrad
=
i i
X D X D (q)(r,0)iEF8 qj ]
D S(r,0) = 3.17x10-2 [ (4) (r,0) iGFS Qj mrad
+
=
i i I WP4.15
I l
i QaT I
i L
M e
L g
a i
a p
G t
i M
i QaT g
i n
M u
L a
T i
M i
QaT y
i e
M n
d i
a K
t i
M S
E S
i A
Q E
a L
d T
E i
i R
o M
S r
SE y
US h
a 1
OO T
t ED 1
i S
M 3
AE GT 0
e A
i 6
r 0L Q
u 5U y
a g
C d
T i
TI o
i F
RT B
M 4, R PA l
P a
a R
t T
F o
i C
T M
0 1
i QaT r
i e
M v
i L
aT i
M i
QaT i
e M
no B
at i
M e
py d
T
)
e h
d ye R
sr S
5 as aa0srs( prnnee l a L
1 wa Hgg B L C C C C u 3 Z Z % "C C aw A
0 0 0 7 t 4 R0 5 5 1
tr T
4 ehe 3 1 3 N99 65 4 4 oo O
P 3 3 4 46 3 s3 ttl 1 1 Tf T
W aae 1 1 1 1 1
1 DPR
o a
Figure 3.12 10 CFR PART 50 GASE0US RELEASES PARTICUt. ATE DOSES DUE TO TRITIUM Date Pathway Inhalation Food Release Release Age Type Qi Group Organ M
M g M
I I
F 0
" a 1i j
ra T
t.ong Child Bone Liver Total Body Thyroid Kidney Lung GI-1.L I Infant Bone Liver Total Body Thyroid Kidney 1.u ng G I l.'. I Short Child Bone Liver Total Body Thyroid Kidney Lung GI-LLI Infant Bone liver Total Body Thyroid K1dney Lung GI-LLI 61 -
.WP4.15
________--______--____-._----__--_----__-_-_----------J
Figure 3.13 10 CFR PART 50 GASEQUS RE'. EASES PARTICULATE DOSES DUE TO GROUND PLANE Nuclide NYTa h)(House' 0
9 Ta 1 Ta 1 Qi qi l
(House'l 3H 131g 133[
t i.oBa 1sola 60Co 137Cs 51Cr 13i.Cs MRu(Rh.I
-::s; 5 '*M n 14 a.Ce t ie lCe 89
- Sr
- YTa 1 h 0
l Totals forwarded j
TOTALS j
62 -
WP4.15
_________________________________________________j
Figure 3.14 Date 10 CFR PART 50 GASEQUS RELEASES Release Type PARTICULATE DOSES page IQi Qi Total 3
D i
X QH X
i QH 3
Dose Dose Age 4
y I
Ground 4
F V
F p
for-p M ra (Field)
MHa ra Da warded Oa Grotm Organ (House)
MI Ta MHa ta Plane (Field) i i
t Child Bone Liver Total Body Thyroid Kidney.
Lung Gi-LLI 1
Infant Bone Liver Tota'i Body Thyroid Kidney Lung Gi 1.LI l
MH ta) + r ( ) House Qi 3.17 x 10-8 [ (q) House (IQj Mita + OH3 3
M ta +
Dra =
j
( ) Field IQi M ta + ( ) Field QH3 MH ta ]
3 i WP4.15
1 0
0 e
APPENDIX A ODG WP4.15
APPENDIX A LACUWR SITE SPECIFIC FACTORS Parameter Definition Value Reference U
Adult fish consumption 21 kg/yr Reg. Guide 1.109 p
BR Breathing rate, child 3700 m /yr 3
Breathing rate, infant 1400 m /yr t
Ground plano exposure period 3.15 x 10 sec.
NUREG-0133 for instantaneous releases.
8 t
Gr und plane exposure period 4.73 x 10 sec. Reg. Guidel.109 b
for cumulative doses SF Shielding factor 0.7 r
Fraction of deposited activity 1.0 for radiciodines retained on cow's feed grass 0.2 for particulates O
Cow's pasture consumption rate 50 kg/ day p
U Milk consumption for age 330 liters /yr (child) ac group a 330 liters /yr (infant)
Y Agricultural productivity of 0.7 kg/m P
pasture feed grass
~1
~
A" Decay constant for removal of 5.73 x 10 sec activity from plant surfaces by weathering t
Transport time from pasture to 1.73 x 10 sec f
cow to receptor 3
11 Absolute humidity 8.0 gr/m f
Fraction of year cow is on 1 (10 CFR 20 releases)
P pasture is (10 CFR 50 releases) l f
Fraction of cow feed that is 1
s pasture grass while cow is on pasture Y
Agricultural productivity of 2.0 kg/m s
stored feed 6
t Transport time from harvest, 7.78 x 10 sec.
h to cow, to receptor U
Meat consumption rate for 41 kg/yr (child) age group a 0 kg/yr (infant)
WP4.15 ODCM
l APPENDIX A LACBWR SITE SPECIFIC FACTORS (Continued)
Parameter Definition Value Reference 6
t, Transport time from pasture 1.73 x 10 sec Reg. Guide 1.10!
g to cow to receptor 2
Y Vegetation areal density 2.0 kg/m y
D Leafy vegetation consumption 26 kg/yr (child at rate for age group a 0 kg/yr (infant) -
f Fraction of fresh leavy 1.0 g
vegetation and consumption 4
t Time between harvest of fresh 8.6 x 10 sec.
=
b leafy vegetation and consumption U
Stored vegetation consumption 520 kg/yr (child) as rate for age group a 0 kg/yr (infant) f Fraction of stored vegetation 0.76 9
grown locally 6
t Time between harvest of stored 5.18 x 10 sec.
hv vegetation and consumption WP4.L5 ODCM
P I
e APPENDIX B tJP4.15 ODCM
x s,
~;, ;
y 4
,' N[
.,.]
^
STABLE ELEMENT TRANSFER DATA
- i F
F (Cow) p g
Element Meat (d/kg) pil_k (d/1) i_
H 1.'2E-02 1.0E-02 C
3.1E-02 1.2E-02 Na 3.0E-02 4.0E-02 P
4.6E 2.5E-02 Cr 2.4E-03 2.2E-03 Mn 8.0E-04 2.5E-04
's Fe 4.0E-02 1.2E-03 Co 1.3E-02 1.0E-03 Ni 5.3E-02 6.7E-03 Cu 8.0E-03 1.4E-02 s
Zn 3.0E-02 3.9E-02 Rb 3.1E-02 3.0E-02 Sr 6.0E-04 8.0E-04 Y
4.6E-03 1.0E-05 Zr 3.4E-02 5.0E-06 Nb 2.8E-01 2.5E-03 Mo 8.0E-03 7.5E-03 Tc 4.0E-01 2.5E-02 Ru 4.0E 1.0E-06 Rh 1.5E-03 1.0E-02 Ag 1.7E-02 5.0E-02 Te 7.7E-02 1.0E-03 I
2.9E-03 6.0E-03 Cs 4.0E-03
-1.2E-02 Ba 3.2E-03 4.0E-04 La 2.0E-04
'5.0E-06 Ce 1.2E-03 1.0E-04 Pr 4.7E-03 5.0E-06 Nd 3.3E-03.
4 5.0E-06 W
1.3E-03 5.0E-04 Np 2.0E-04 5.0E-06 Br.
.2.9E-03**
1.4E-02***
- t..
3 i
- Data presented in this table are from NRC Regulatory Guide 1.109, Revision 1, October 1977.
- Used;value for_-1 (no literature available.)
- W. C. Ng, " Transfer coefficientsf for Prediction of the Dose to Man Via.
the Forage-Cow-Milk Pathway from Radionuclides Released to _ the Biosphere,"
UCRL-51939.
l WP4.15 00CM
1 i
f BIOACCUMULATION FACTORS TO BE USED i
IN THE ABSENCE OF SITE-SPECIFIC DATA (pCi/kg per pCi/ liter)
- ELEMENT FRESHWATER FISH H
9.0E-01 C
4.6E403 Na 1.0E+02 P
1.0E+05 Cr
,2.0E402 Hn 4.0E402 Fe 1.0E+02 Co 5.0E401 Ni 1.0E402 Cu 5.0E401 Zn "
2.0E403 Br
.4.2E402 Rb 2.0E403 Sr 3.0E401 Y
2.5E401 Zr 3.3E400 Nb
'3.0E404 Ho 1.0E401 4
Tc l.5E401 Ru 1.0E401 Rh 1.0E401 Te 4.0EiO2 I
1.5E401 Cs 2.0E403 Ba 4.0E400 La 2.5E401 Ce 1.0E400 Pr 2.5E401 Nd 2.5E401 W
l.2E403 NP 1.0E401 A8
- 2. 3E400 * *
- Table A-1, Regulatory Guide 1.109, Rev.1,1977.
- S. E. Thompson, " Concentration Factors of Chemical Elements in Edible Aquatic Organisms," UCRL-50564, Revision 1,1972.
WP4.15 ODCM
e 9
e
{
APPENDIX C i
VP4.15 ODCM
e i
INHALATION DOSE FACTORS FOR ADULTS (mrem per pCi Inhaled) 1 i
(tVCL I CE 80NE liver T.ROCY THYRDID KIDNEY LUNG GI-LLI H
J NO DATA t.58E-07 1.58F-07 1.59E-C7 1 58E-07 1.58E-07 L.58E-07 C to 2.27E-06 4.26E-07 4.26E-0T 4.26E-07 4.260-07 4.26E-07 4.26E-07 1A 24 1.28E-06 1.28E-06 1.26E-06 1.28E-C6 1.28E-06 1.2AE-06 1.28E-06 P 32 1.65E-04 9.64E-06
- 6. 26 E-0 6 ND DATA NC DATA NO DATA 1.08E-05 LR 51 NO DATA NO DATA 1 2 S E-0 8 T.44E-09 2.ASE-09 1.80E-06 4.15E-07 MN 54 NO DATA 4.9)E-06 F.81E-OF NO DATA 1.23E-06 1.75E-04 9.6TE-06 MN 56 NU DATA 1.55E-10 2.??E-tt NO DATA 1 63E-10 1.18E-06 2.53E-06 FE 55 l.0FE-06 2.12C-06 4.9tE-07 NO D4TA NO DATA 9.CtE-06 F.54E-07 FE 59 1 47E-06 1.4TE-00 1.3/E-06 NO DATA NO DATA 1 27E-04 2.35E-05
__..............__......__.....1 16E-04 1.13E-05 CO 58 90 DATA 1.98E-0 F 2.59E-07 NO CATA NC DATA EO 60 NO DATA 1.44E-06 1.85E-06 NU DATA NO DATA T.46E-04 1.56E-05 NI 6 5 5.40E-05 3.73E-06 1.8tE-06 40 DATA NO DATA 2.23E-05 1 67E-06 11 65 1.92E-10 2.62E-11 1.14F-11 NO DATA NC DATA 7.00E-07 1 34E-06 EU 64 NO DATA 1.53E-10 T.67E-Lt NO DATA 5.78E-10 6.48E-07 6.12E-06 ZN 65 4.05E-06 1.29E-05 4.82C-06 NO DATA R.62E-C6 1 08E-04 6.68E-06 IN 69 4.23t-12 8.14E-12 5.65E-13 NO DATA 5.27E-12 1.15E-07 2.04E-C9 dR 83 NO DATA 40 D AT A 3.01E-08 NO DATA NO DATA M0 DATA 2 90E-08 HR 84 NO DATA NO OATA 1.9tE-08 90 DATA NO DATA NO DATA 2 05E-13 dR 85 NO DATA NO DATA t.60E-09 NO DATA NO DATA NO DATA LT E-24 9e 80 NU OATA 1 61C-05 7.3tE-06 NO DATA NO DATA hu DATA 2 08E-06 90 88 NO DATA 4.P4E-08 2.41E-98 NO DATA NO DATA NO DATA 4.18E-19 48 89 NU DATA 3.2CE-08 2.126-08 NO DATA NC DATA NO DATA 1.16E-21 SH 89 3.80E-05 NO DATA 1.09E-06 NO DATA NO DATA 1.75E-04 4.37E-05 SR 90 1.24E-02 NO CATA 7.62E-04 NO DATA NC DATA 1.20E-03 9.02E-05 l
5R 91 7.?4E-09 NO DATA 3.IIE-10 NO DATA NO DATA 4.56E-06 2.39E-05 SR 92 8.43E.tn NO DATA l.64E-It NO DATA NO DATA 2.06E-06 5.38E-06 j
Y 90 2 61E-07 NO DATA
- 7. 01 E -0 9 NO DATA 90 DATA 2.12E-05 6.32E-05 i
Y 9tM 3.26E-It NO DATA 1.2TE-12 NO. DATA NC OATA 2.40E-07 1.66E-10 Y 91 5.78E-05 NO DATA
- 1. 5 5 E-0 6 40 DATA NO DATA 2.13E-04 4.8tE-05 Y 92 1.29E-09 NG UATA 3.TTE-Il NO DATA NC DATA 1.96E-06 9.19E-06 WP4.15 ODCM
s NUCLIJL BONE LivFR T. fluaf THYROID KIONFY LUNG GI-LLI Y 91 1 186-06 NO UAIA S.26E-10 NO DATA NC OAT A 6.06E-06 5.27E-05 in 95 1 34E-05 4.3CE-06 2.9tE-06 NO DATA 6.77E-06 2.2tE-04 1.88E-05 24 9F 1.21E-08 2.45C-09 1.11E-09 NO DATA 3.71E-09 9.84E-06 6.54E-05 NR 95 t.760-06 9.f7L-OF 5.26E-07 NO DATA 9.67E-07 6.3tE-05 1.30E-05 MO 99 10 DATA t.5tL-08
- 4. 61E-12 NO DATA S.52E-12 9.55E-08 5.20E-07 TC101 5.22E-15 7.52E-15 f.)dE-14 No DATA 1.156-13 4.99E-08 f.36F-21
.dul01 1.9tE-07 NU OATA
- 8. 2 J E -0 8 NO DATA 7.29E-07 6.1tE-05 1.38E-05 Hut 05 1.8BE-It NO DATA 3.89C-11 NO DATA 1.27E-10 1.37E-06 6.02E-06 Rul06 8.64f-C6 NO DATA 1.010-06 NO DATA 1.67E-05 1.17E-03 1.14E-04 ACitnF L.35C-06 1.256-06 F.45E-07 nu OATA 2.46E-06 5.79C-04 1.78E-05 ICl?SM 4.27E-07 1.99C.07 5.84E-OS
- t. llc-07 1.55d-06 3.92E-05 8.83E-06 TEt27P 1.58E-06 7.?lt-67 1.96E-07 4.1tE-07 5.72E-06 1.20E-04 1.87E-05 TEt2r 1.75C.10 H. 01'i-I l 1.8FE-It 1.12E-10 6.37E-10 8.14E-07 7.17E-06 IC129*
1.22E-06 5.b4C-07 1.9aE-0F 4.30E-07 4.57E-06 1.4SE-04 4.79E-05 ICl29 6.22C-12 2.99E-12
- 1. 5'a E -12
- 4. 8 7t-12 2.14E-11 2.42E-07 1.96E-08 IClllM 8.f4E-09 5.45E-09 J.63r-09 6.48F-09 1.86E-08 1.82E-05 6.95E-05 (F131 1.39E-12 7.44E-11 4.49E-13 1.17E-12 5.46E-12 1.74E-07 2.30E-09 TE112 1.25E-08 2.69E-08
- 2. 02 E-0 8 2.37E-08 1.82E-07 3.60E-05 6.37F-05 I 130 5.72E-07 1.68E-06
- 6. 60C-0 7 1.42E-04 2.61E-06 NO DATA 9.61E-07 I 131 3.15E-06 4.47E-Oo
- 2. 56C-0 6 1.49E-03 7.66E-06 NO DATA 7.85E-07 I 112 1.4SE-07 4.07E-07 1 4SE-0 7 1.43E-05 6.48E-07 NO DATA 5.08F-08 I 131 1.08E-06 1 85E-06
- 5. 6SE-0 7 2.69E-04 1.23E-06 NO DATA 1.11E-06 1 114 8.0SE-08 t.16C-07 F.69E-08 3.73E-06 3.44E-07 NO DATA 1.26E-10 I 135 1.35C-C7 8.73E-07
- 3. 21 E-0 7 5.00E-05 1.19E-06 NO DATA 6.56E-07 C5134 4.66E-05 1.06E-04 9.10 E-0 5 NO DATA 3.59E-05 1.22E-05 1.30E-06 C5136 4.88E-06 1.83E-05 1.38E-05 NO DATA 1.07E-05 1.50E-06 1.46E-06 C5137 5.98E-05 7.76E-05 S. 35C-0 5 NO DATA 2.78E-05 9.40E-06 1.05F-06 C5138 4.14E-08 7.T6E-08 4.0 iE-0 8 NO DATA 6.00E-08 6.07E-09 2.33E-13 ttA139 1.17E-10 8.J2E-14 3.'?C-12 NO DATA
- 7. 7 8 E -l '.
5.70E-07 1.12E-07
.....__....___......__....__.+.. __....___....___..
r..
1 WP4.15 ODCM
e NUCL I CE BONE tivCR f.dbcY THYROID KIDhEY LONG GI-LLI nAl40 4.98t-C6 6.13F-09 l.2 t E-O F NO CAIA 2.09E-09 1.59E-04 2.73F-05 mal 41 1.25E-Il 9.4tE-15 4.20E-13 NO DATA 8.75E-15 2.42E-07 1.45E-17 RA142 3.29E-12 3.385-15 2.07E-Il NO DATA 2.96E-15 1.49E-07 1.96E-26 L Al40 4.50E-C8 2.17E-08 5.71E-01 NU OATA NO DATA 1.70E-05 5.73E-05 L A142 8.$4E-ti S.88E-Il 9.64E-12 NO DATA NO DATA 7.9tE-07 2.64E-07 CEl41 2.49E-06 1.692-06 1.91L-01 No car 4 7.83E.07 4.52E-05 1.50E-05 CFt43 2.llE-C4 1.F2E-06 L. 91 L -01 NO Daft 7.60E-69 9.97E-06 2.83E-05
- E144 4.29E-04 1.79E-04
- 2. 30F -0 5 NO DAT4 1.06E-04 9.72E-04 1.02E-04 P4143 1.lTE-06 4.69E-97 5.996-08 Nn Data 2.70E-07 3.5tE-05 2.50E-05
..__~.... ___..........................___..___............___.._____...__..
PR144 1.76E-12 1.265-12 1.9tE-13 NO DATA 8.816-13 1.27F-07 2.6?E-18 1014F 6.S9E-07 7.62E-0F
- 4. 5 6 E-0 8 NO DATA 4.45E-07 2.7bE-05 2.16E-05 W 187 1.06E-09 8.85E-13 3.10E-10 NO DATA NO DATA 3.63E-06 1.94E-05
..................__..a_..........
NP239 2.B TE-08 2.82E-09
- 1. 5 % E-0 9 NO DATA 8.75E-09 4.70E-06 1.49E-05 i
i f
i WP4.15 oo(3g
4 INHALATION DOSE FACTORS FOR INFANTS (mrem per pCi Inhaled)
NUEL 10E BUNE LIVER T..t n 0Y fitVROID KIDNEY LUNG GI-LLI P
J NU OATA 4.62E-07 4.620-07 4.62F-07 4.62E-07 4.62E-07 4.62E-07 C 14 1.89E-05 1.19E-06
- 3. 79E-0 6 3.796-G6 5.79E-06 1.79E-06 3.79E-06 24 F.54E-C6 T.54E-06
- 7. 5 4 E-0 6 7.54E-06 7.54E-06 7.54E-06 7.54E-06
'_ A P l2 1.45E-03 8.03E-05 5.53E-05 NO DATA NO DATA NO DATA 1.15E-05 CR 51 NO DATA NO DATA
- 6. 5 9 E-0 8 4.tlE-08 9.45E-09 9.17E-06 2.55E-07 MN 54 NO DATA 1.8tE-05 3.56E-06 NO DATA 3.56E-06 7.14E-04 5.04E-06 NN 56 NO DATA 1.10F.-09 1.58E-10
.40 U A T A 7.86E-10 8.95E-06 5.1?E-05 FE 55 1.4tE-05 H.39C-06 2 38E-06 NO UATA NO DATA 6.21E-05 7.82E-07 FE 51 9.69E-06 1.682-05 6.77E-06 NO DATA NO DATA 7.25E-04 1.77E-05 CD 58 40 DATA 8.7tE-07 1.30E-36 NO DATA NO DATA 5.55E-04 7.95E-06 CO 60 NO DATA 5.73E-06 8.41E-06 NO DATA NO DATA 3.22E-03 2.28E-05
'41 69 2.42E-04 1.46E-05
- 8. 29 E-0 6 NO DATA NO DATA 1.49E-04 1.73E-06 NI 65 1.71E-09 2.Olt-10 u.79E-ti NO DATA NO DATA 5.80E-06 3.58E-05 CU 64 NO CATA 1.34E-09
- 5. 5.4 E-10 No DATA 2.84E-09 6.64E-06 1.07E-05 IN 65 1.18E-05 4.97F-05 2 22E-05 NO DATA 2.32E-05 4.62C-04 3.67E-05 IN 69 3.85E-11 6.9tE-ti 5.tsE-12 No DATA 2.87E-Il 1.05E-06 9.44E-06 RR 83 NO DATA NO DATA
- 2. 72 E-0 7 NO DATA NO DATA NO DATA LT E-24 HR 84 NO DATA NO DATA 2.86E-07 NO DATA NO DATA NO DATA LT E-24 CR 8>
NO DATA NO DATA 1.46E-08 NO DATA NO DATA NO DATA LT E-24 20 86 NO DATA t.360-04 6.30E-0$ HD DATA NO DATA NO DATA 2.17E-06 10 88 NO DATA 3.98E-07 2.03E-0 7 NO DATA NO DATA NO DATA 2.42E-07 i
RB 89 NO DATA 2.29E-07
- 1. 4 7 E-0 7 NO DATA NO DATA NO DATA-4.87E-08 i
5R 89 2.84E-04 NO DATA 8.15E-06 NO DATA NO DATA 1.45E-03 4.57E-05 i
%R 90 2.92E-02 NU DATA 1.85f-03 NO DATA NO DATA 8.03E-03 9.36E-05 SR 91 6.83E-08 NO DATA 2.4TE-09 NO DATA NO D'ATA 3.76E-05 5.24E-05 54 92 7 5GE-09 NO DATA 2.79E-10 NO DATA NO DATA 1.70E-05 1.00E-04 Y 90 2.35E-06 NU OATA
- 6. 3 0E-0 8 No DATA NO DATA 1.92E-04 7.43E-05 Y 917 2.9tE-10 NO DATA 9.90E-12 N0 UATA NO DATA 1.99E-06 1.68E-06 Y 91 4.20E-04 NO DATA 1.12E-05 NO DATA NO DATA 1.75E-03 5.02E-05 Y 92 1.17E-08 NO DATA 1.29E-10 NO DATA NO DATA 1.75E-05 9.04E-05 j
WP4.15 ODCM
e
'aOCL I CE BONE LIVER f.800Y THY.10lO KIONEY LUNG GI-LLI Y 91
- 1. 0 7 E.0 7 NO DATA
- 2. 91 E-0 9 NO 04TA NO DATA 5.46E-05 1.19E-04 (R 95 d.24C-0) 1.19E-05
- 1. 45 E -0 5 NO DATA 2.22t-n5 1.25E-01 J.55E-05 24 97 1.070-07 1.83E-08 8.16C-09 40 DATA 1.85E-08 7.88E-05 1.00E-04 ran 95 1.12E-05 4.59E-06 2.70E-06 NO DATA 3.57E-06 3.42E-04 9.05E-06 MO 99 40 04TA t.18c-07
- 2. 3 t E-0 8 NO DATA 1 89E-07 9.63E.05 3.48E-05 IC 99M 9.98C-11 2.06E-12 2.66E-11 NO DATA 2.22E-11 5.79E-07 1 45E-06 TClot 4.65E-14 5.99E-14 5.80E-1)
NO DATA 6.19E-13 4.17E-07 6.03E-07 AU103 1.44E-06 40 04TA 4.85C-0 7 NO DATA 1.01E-06 1.940-C4 1.15E-05
.4U105 8.74E-10 NU OATA 2 9tE-10 NO DATA 6.42E-to 1.12C-05 3.46E-05 AUl06 6.20E-05 NU DATA
- 7. 7 TC-0 6 NO UATA 7.61E-05 8.26E-03 1.17E-04 4Gtt04 7.13F-06 5.16C-06
- 1. 5 7 E-0 6 NO DATA 7.80E-06 2.62E-03 2.36E-05 IEt25M 3.40E-06 1.42 -06 4.70E-07 1.16E-06 NO DATA 3.19E-04 9.22E-06 TE127M 1.19E-05 4.93E-06 1 406-06 1.48E-06 2.63E-05 9.37E-04 1.95E-05 TE127 1.59E-09 6.stt-to 3.49E-10 1.32E-09 3.47E-09 7.39E-06 1.74F-05 TE129 t.01E-05
- 4. 35E-06 ' 1 59E-06 1.9tE-06 2.27E-05 1.20E-03 4.93E-05 TC129-5.63E-It 2.48E-11 1.34E-11 4.82E-11 1.25E-10 2.14E-06 1.88E-05 TE13tM 7.62E-C8 1.13E-08
- 2. 51E-0 8 6.38E-08 1.89E-07 1.42E-04 8.51E-05 TEt31 1 24E-It 5.87E-12 3.5 7E-12 1.13E-11 2.85E-11.t.47E-06 5.87E-06 TE132 2.66E-07 1.69F.07 1.26E-07 1.99E-07 7.19E-07 2.43E-04 l.15E-05 1 130 4.54E-06 9.9tC-06 3.9RE-06 1.14E-01 1.99E-05 NO DATA 1.42E-06 I 131 2.7tE-05 3.175-35 1.41E-05 t.06C-02 3.70E-05 NO 04T4 7.56E-07 I 132 1.2tE-06 2.53E.06
- 8. 99E-0 7 1.2tE-04 2.p2E-06 NO DATA t.36E-06 I til 9.46E-06 1.l7E-05 4.00E-06 2.54E-03 1.60E-05 NO DATA 1.54E-06 f 134 6.58E.07 t.34C-06
- 4. 75E-0 7 1.18E-05 1.49E-06 NO DATA 9.21E-07 I 135 2.76C-06 5.*lF-06 1.99E-06 4.97E-04 6.05E-06 JNO DATA 1.3tE-06 C5134 2.83E-04 5.02E-04 5.32E-05 NO DATA 1.16E-04 5.69E-05 9.53E-07 i
C5136 3.45E-05 9.01E-05 3.750-05 NO DATA 4.03E-05 8.40E-66 1.02E-06 i
3 C5117 3.92E.04 4.lTF-04 3.2dE-05 NO" DATA 1.23E-04 5.09E-05 9 530-07 l
4.67E-08 6.26F-07 i
C5t38 1.6tE-07 5.48C-07 2.84E-07 NC CATA 2.91E-07 ~ 4.25E-063.64F-05 Ball 9 1.06E-01 7.91[-13 J.07C-11 40 DATA 4.21E-13 NP4.15 ODCM i
i l
e NHCLICE BONE LivtR I.nUUY THvRoto KIONtv tuNG GI-LLI MA140
.4.00E-05 4.COE-CP 2.07F-96 NO DATA 9.590-09 1.14F-03 2.74E-05 e4141 1.12E-10 7.700-14 S.55t-12 NO DATA 4.64L-14 2.12E-06 l.39F-06 64142 2.04E-11 2.365-14 1.4CE-I2 NO DATA 1.36L-14 1.1tE-06 4.95E-07 1A140 n.6tE-C7 1.43t-97 t.6di-00 e0 DATA NO DATA 1.20E-04 6.96E-05 L At42 7.36E-lO 2. t.9 t. - 10 h.4pE-tt 40 DATA NO DATA 4.8FF-06 4.25E-05 CEt41 1 18E-05 1 19E-05 1.4/t-06 NO UArA 1.T5t-06 s.69E-04 1.54C-05 CE143 2 390-07 1.49E-97 1.5MF-08 NH DATA 4.03E-04 R.3CE.n5 3.SSE-05
- Et44 2.28E-03 8.o56-04 1.2bE-04 NU OAIA 3.M4E-04 7.0lE-03 1.16E-04 94143 1 00E-05 1.74E-Oo 4.910-07 N9 UATA 1.4tE-06 3.09E-04 2.66E-05 PR144 1.426-11 1.32C-It 1.720-12 NO CATA 4.40E-12 1.15F-06 3.06E-06 3014r S.6fE-Oh 5.81F-06 1.57E-07 NO DATA 2.25t-96 2.J0E-04 2.23E-05 W 187 9.260-09 6.44E-09 2.2SE-01 NO UATA NO DATA
?.83E-05 2.54E
.................................................................______-05 NP219 2.65E-07
- 2. 570-08 1.14 E-0 3 NO DalA 4.75L-05 4.25E-C5 1.78E-05~
t 4
WP4.15
'ODCM
t i
1 i
l i
INGESTION DOSE FACTORS FOR ADULTS (mrom per pCi Ingested) i uuCLII.E RONE liver T.ROGY THYRDID KIDNEY LUNC GI-LLI H
NU UATA 1.05C-01 t.CS E-0 7 1.056-07 1.05E-07 1.05E-07 1.05E-07 C 14 2.84E-06 5.68E-07 5.6 8E-0 7 5.66E-07 5.68E-07 5.68E-07 5.68E.07 NA 24 1.70F-06 1.70F-06
- 1. 70 E-0 6 1.10E-06 1.70E-06 1.70E-06 1.70E-06 P
12 1.93E-04 1.20E-05
- 7. 4 6 E-0 6 NO UATA NC DATA NO DATA 2.17E-05 CR 51 NO DATA NO CATA 2.600-09 1.51E-09 5.86E-10 3 53E-09 6.69E-07 NN 54 NO DATA 4.575-C6 S. 72 E-0 7 NO DATA 1.36E-C6 NO DATA 1.40E-05 NN 56 NO DATA 1.1$C-07 2.04E-04 NO DATA 1.46E-07 NO DATA 3.67F-06 rC 55 2.75E-06 1.40F-06 4.4 sC-0 7 NO DATA NO DATA 1.06E-06 1.09E-06 FE 59-4.34E-C6 1.C2C-05
- 3. 91 E-0 6 NO DATA NO DATA 2.85E-06 3.40E-05 4C0 54 NO DATA 7.4Sd-07
- 1. 6 7 E.0 6 10 UATA NO DATA NO DATA 1 51E-05 CO 60 NO DATA 2.14F-06 4.72C-06 NO DATA NO DATA NO DATA 4.02E-05 41 63 1.30E-C4 9.01E-Co 4.36E-06 NO DATA NU DATA NO DATA 1.88E-06 NI 6s 5.28E-07 6.u6E-08 3.1)E-08 NO DATA NO DATA NO DATA 1.74E-06 CU 64 NO DATA 6.3)~-03 3.91[-08 NO DATA 2 10E-07 NO DATA 7.10E-06 IN os 4.84E-06 1.34E-05
- 0. 90 E-0 6 No DATA 1 03E-05 NO DATA 9.70E-06 2N 69 1.0lE-08 1.17C-08 1.3FF-09 No DATA 1.28E-08 NO DATA 2.96E-09 HR 83 40 DATA NO DATA
- 4. 02 E -0 8 NO DATA NO DATA NO DATA 5.79E-08 MR 84 NO DATA NO DATA 5.21E-08 NO DATA NO DATA NO DATA 4.09E-13 BR 8%
NO DATA NU UATA 2.14 E-0 9 NO DATt NO DATA NO CATA LT E-24 RR d6 NO DATA 2.1 t E 9.n 3 E-0 6 NO DATA NO DATA NO DATA' 4.16E-06 R8 A8 NO DATA 6.05E-08 S.21E-04 NO DATA MO DATA No DATA 8.360-19 M9 89 NO DATA 4.01E-08 2.82[-08 NO DATA NO DATA NO DATA 2.33E-21 SR 89 3.08E-04 NO DATA
- 8. 84 E -0 6 NO DATA NO DATA-NO DATA 4.94E-05 SR 90 7.58E-03 NO DATA t.86E-0)
NO DATA NO DATA NO DATA 2.19E-04 SR 91 5.6TE-06 NO DATA 2.29E.9T NO CATA NC DATA NO DATA 2.70E-05 SR 92 2.15E-06 NO DATA 9.30E-05 NO DATA NC DATA NO DATA 4.26E-05 j.
Y 90 9.62E-09 NO DATA
- 2. 5 8 E-10 NO DATA NG DATA NO DATA.
1.02E-04 Y 9tM 9.09E-It NO OATA 3.52C-12 40 CAT 4 NO DATA NO DATA 2.67E-10 Y 91 1.41E-0.7 NU DATA 3.77C-04 NO DATA NO DATA No DATA 7.76E-05 Y 92 8.45E-10 NO CATA 2.47E-11 NO DATA No DATA NO DATA 1.48E-05 l
t JWP4.15 ODcM
NUCLluE SUNE LIVcR T.h0CY THY 90lc KIDNEY LUNG GI-LLI Y 96 2.68E-09 No UATA 7.49E-11 40 DATA NO DATA NO DATA n.50E-05 IR 95 3.04E-OP 1.75E-09 6.60E-09 NO DATA 1.53E-08 NO DATA 3.09E-05 IR 9T 1.68E-09 3.392-10 1.55E-LO NO DATA 5.12E-10.NO DATA 1.05E-04 NR 95 6.22E-09 3.46E-09 1.86E-09 NO CATA 3.42E-C9 NO DATA 2.10E-05 MO 99 NO DATA 4.31E-06
- 8. 20E-0 7 40 DATA 9.76h-06 NO DATA 9.99E-06 TC 99M 2.47E-10 6.98E-10 8.89E-09 NO DATA 1.06E-08 3.42E-10 4 13E-07 TClot 2.54E-10 3.66E-10
- 3. 59 E-09 NO DATA 6.59E-09 1.87E-10 1.10E-21 tulo) 1.85E-07 NO DATA 7.97E-08 NO DATA 7.06E-07 NO DATA 2.16E-05 2U109 1.54E-08 NO CATA 6.0SE-09 NO DATA 1.99E-07 NO DATA 9.42E-06 Mut06 2.f5E-06 NO DATA
- 3. 4 S E -0 7 NC OtT A 5.3tE-06 NO DATA 1.78E-04 j
AG110M 1.60E-07 1.48E-97 8.79E-08 NO DATA 2.9tE-07 NO DATA 6.04E-05 TE125M 2.69E-06
- 9. TIE-07 3.59E-07 8.06F-37 1.09E-05 NO CATA 1.07E-05
\\
T5127*
6.77E-06 2.42C-06 8.25E-0 7 1.73E-06 2.15E-05 NO DATA 2.27E-05 TE127 1.10E-07 3.95E-08
- 2. 3 H E-0 8 n.tSE-08 4.48E-07 NO DATA 8.68E-06 TEt29M 1.15E-05 4.298-00 1.A2E-06 3.95E-06 4.8CE-05 NO DATA 5.79E-05 TEt29 3.14E-08 1.t8E-08 7.63E-09 2.4tE-08 1.32E-07 NO DATA 2.37E-03 TElllM 1.73E-06 8.46E-07 7.~05E-0 7 1.340-06 8.57E-06 NO DATA 8.40E-05 TElli 1.97E-08 4.23E-09 6.22E-09 1.62E-08 S.63E-08 NO DATA 2.79E-09 TE132 2.52E-06 t.65E-06
- 1. 5 s E-0 6 1.80E-06 1.57E-05 NO DATA 7.71E-05 1 130 7.56E-07 2.23E-06
- 8. 40E-0 7 1.89E-C4 3.48E-06 NO DATA 1.92E-06 1 131 4.165-06 5.95E-06 3.4tE-06 1.95E-03 1.02E-05 NO DATA 1.57E-06 1 132 2.01E-07 5.43F-07 1.90E-0 7 1.90E-05 8.65L-07 NO DATA 1.02E-07 I 133 1.42E-06 2.47E-06 7.5 3E-0 7 3.63E-04 4.31E-06 NO DATA 2.22E-06 l 134 1.06E-07 2.88E-07 1.03E-0T 4.99E-06 4.58E-07
,NO DATA 2.5tE-10 l
I 135 4.43E-07 1.16E-06
- 4. 2 SE-0 7 7.65E-05 1.46E-C6 NO DATA t.3tE-06 i
C$134 6.22E-05 1.48E-04 1.2 t E-0 4 NO DATA 4.79E-05 1.59E-05 2.59E-06 CSI16 6.5tE-06 2.575-05
- 1. 85 E-0 5 NO DATA 1.43E-05 1.96E-06 2.92E-06 C$137 T.97E-05 t.C9E-04 '7.14E-05 NO DATA 3.70t-05 1.23E-05 2.ItE-06 C$138 5.52E I.01E-07 5.40E-08 No DATA 8.01E-08 7.9tE-09 4.65E-13 8At39 9.70E-08 6.9tE-It
- 2. 84 E -0 9 NO DATA 6.46E-It 5.92E-Lt 1.72E-07 WP4.15 ODCM
I l
MUCLIFE BONE LIVER T. il0DY THYROIO KIDNEY LUNG GI-LLI
'l A 14 9 2.0$C-C5 2.55E-0$
1.31E-06
'40 OATA R.67t-09 1.46E-08 4.18E-05 P.4141 4.ilE-08
't. 4 6E-I t 1 51E-09 NO DATA 3.31E-It 2.02E-11 2.22E-17 HA142 2.13E-CA 2.19E-Il
- 1. 34 t -9 9 10 DATA 1.S$F-tt 1.24E-LI 1.00E-26 LA140 2.50l-09 1.26J-09 3.3JE-10 NU OAT 4 NO DATA NO DATA 9.25E-05 L A142 1.28E-10 5.82C-tt 1 450-11 t40 DATA NC DATA NO DATA 4.2SE-07 CEt4L 9.36E-01 6.13E-09 T.19E-tC NO Daft 2.940-09 NO DAT4 2.42E-05 CEt43 1.65E-C1 1.227-06
- 1. 3 5 E -10 NO DATA 5.37E-10 NO DATA 4.56E-05 CE144 4.R8E-07 2.04E-07 2.62E-08 NO DATA 1.2tE-07 NO DATA 1.65E-04 PRt45 9.20E-09 3.69:-09 4 56E-10 NO DATA 2.13E-09 NO DATA 4.03E-05 Pal 44 3.01E-It 1.255-11 1.590-12 No DATA 7.05E-12 hp DATA 4.31E-18 4014F 6.29E-C9 7.27E-09
- 4. 45E-10 NO DATA 4.25E-09 NO DATA 3.49E-05 h tit 1.03E-07 9.6tE-08 3.01E-38 No DATA NO DATA NO DATA 2.82E-05 i
tJP239 1.19E-09 1.170-10 6.45E-11 NO DATA 3.65E-10 NO DATA 2 40E-05 f
t 1
WP4.15 ODCM l
i
.J
4 INGESTION DOSE FACTORS FOR INFAN'IS (mrem per pCi Ingested) 4 HCL ICL BUNE
.Livd4 T. 60 s,Y IHY1010 nIONCY LUNG GI-LLI H
s NU DATA' 3.0e"-0T s.ciC-0 7 s.69F-07 1.00L-07 3.COC-OF 3.08E-07 L
I4 2.)FF-05 b.C60-Ob
- 5. 0 0C-0 6 5.06C-06 5.C6t-06 5.06F-06 5.06C-06 NA 24 1.016-05 1.UIC-03
- 1. 0 t t -9 5 I. G I C-f.5 1.01E-05 1.01E-05 1.01E-05 e 32 1.706-03 1.001-04
- 6. 5 9t -0 5 40 UATA NO DATA ND DATA 2.10E-05 OA 51 NU UATA NO DATA t.4tE-os 1.20E.09
/.otE-09 1.79E-08 4.ttE-07 AN S4 NO DATA-1.995-02
- 4. 51 t -0 6 NO DATA 4.416-06 NO CATA 7.3tE-06 HN 56 NU DAT A A.18E-07 1.4 t F-0 7 10 UATA 7.016-07 NO DATA 7.43F-05 ft 55 1.39E-05 8.18E-06 2.4CC-06 NO DATA NO DAIA 4.19 E-06 1.14E-06 i
rF 59 3.08E-05 5.385-02 2.12E-05 NU CATA NU DATA 1.59E-05 2457F-05 CD Ss NO OtTA 3.60E-06 8.93r-06 NO DATA 10 DATA NO UATA A.97C-06 CG 60 NO UAIA 1.086-05 2.55E-05 NO DATA NO DATA NO DAtt 2.5FE-05 NI 65 6.14E-04 3.926-05 2.29E-05 NO DATA 10 UATA NO CATA 1.95E-06 I
4I 63 4.70E-06 '5.32C-OF 2.426-07 NO DATA 40 DATA NO DATA 4.05E-05 j
%D 64 NO DATA 6.09t-0T 2.8/E-07 NO DATA 1.03C-06 NO DAT4 1.25E-05 IN 63 1.14E-05 6.416-05
- 2. 9 t E -0 5 NU UATA 1.06E-05 NO DATA 5.33E-05 l
fN 69 9.33E-08 1.68C-0F 1.250-08 NO DATA 6.18E-04 NO DATA 1.3FF-05 HR 63 NO DATA HO DATA 3.63 E-0 7 NO GATA NO DATA NO DATA LI E-24 hR S*
NO DATA.
NG UATA
- 3. AJE-0 7 NO OtTA NO DATA NO DATA LT E-24 dR 84 NO DATA NO DATA
- 1. 94 C -0 4 Nn DATA NG.04TA.
NO DATA LT E-24 HM 86 NO DATA 1.10E-04 8.400-05 NO DATA NO DATA NO DATA 4.35E-06 An 88 NO DATA 4.98C-07 2.73E-Of NO DATA NO DATA.
NO DATA 4.850-07 MP $9 NO DATA 2.U6E-07 t.9FE-17 140 b A T A NC UATA NO DATA 9.74E-08 53 89 2.5tE-03 NG DATA
- 7. 20E-0 5 NO DATA NO DATA NO DATA 5.16E-05 SR 90 1.056-C2 NU UATA 4.7tE-0) 40 UATA NO DATA NO D AT A -
2.3tE-04 54 91 5.00E-C5..NU-04T4 1.8tE-06 NO DATA NO DATA NG DATA 5.92C-05
%M 92 1.92C-05 NO DATA 7.13E-07 NO CATA NO DATA NO DATA 2.07E-04 Y 90 A.69E-08 40 DarA 2.3sE-09 NO CATA NO DATA NO DATA 1.20E-04 Y 9tm 8.10E-tC NO DATA
-2.76E.tt ha DATA NU DATA NO DATA 2.70E-06 I
NO 'ATA NO DATA NO DATA 6.10E-05 Y 91 1.13E-06.40 DATA 3.0tE-08 J
Y 92 7.65E-09 NO DATA 2.15E-10 NO DATA NO DATA NO DATA 1.46E-04 1
)
-WP4.15 ODCMJ l
~
. - \\
l l
NUCLICE DONE liver T.000Y THYR 010 KIONEY LUNG GI-LLI Y 93 2.41E-08 NO DATA 6.62E-10 NO DATA NO DATA NO DAin 1.92E-04 ZR 95 2.06E-07 S.02E-08
- 1. 56 E -0 8 NO DATA 5.41E-08 NO DATA 2.50F-05 I
IR 97 1.48E-08 2.54E-09 1.16E-09 NO DATA 2 56E-09 NO DATA 1.62E-04 No 95 4.20E-08 1.73E-08
- 1. 00E-0 8 NO DATA 1.24L-08 NO DATA 1.46E-05 MO 91 NO D4TA 3.4C2-05
- 6. 6 3 E-0 6 NO DATA 5.08E-05 NO DATA 1.12E-05 TC 91F 1.92E-09 3.961-09 5.10E-OS fin 74TA 4.26t-0A 2.0TE-09 1.155-06 TC10L 2.27E-09 2.86E-09
- 2. 8 3 E-0 0 NO DATA 3.40E-0R 1.56E-09 4.86E-07 A0103 1.48E-06 NO UATA
- 4. 95E-0 7 NO DATA 3.08E-06 NO DATA 1.80E-05 10105 1.36E-07 NO DATA 4.5.lE-08 No 0ATA 1.00E-06 NO DATA 5.41E-05 MU106 2.41E-05 NO DATA 3.01E-06 NP OATA 2.45E-05 NO DATA 1.83F-04 4Gtt0M 9.96E-07 7.27C-07 4.81E-07 NO DATA t.04E-06 NO DATA
_3.77E-05 TC12SP 2.33E-05 7.79C-06 3.lsE-06 7.84E-06 NO DATA NO DATA 1.tlE-05 TE127F 5.850-05 1.44E-05
- 7. c n E-0 6 1.69E-05 1.44E-04 NO DATA 2 36E-05 TEl27 1.00E-06 3.355-07 2.15 E-0 7 8.14E-07 2.44t-06 NO DATA 2.10E-05 TC129H 1.00E-04 3.43F-05
- 1. 54 E-0 5 3.84E-05 2.50E-04 tic.0ATA 5.97E-05 TE129 2.84E-07 9.79E-06 6.61E-08 2.38E-07 7.07E-07 NO DATA 2.27E-05 TE131*
1.52E-05 6.12E-06
- 5. 05E-0 6 1.24E-05 4.21E-05 NO DATA 1.03E-04 IE131 1.76E-07 6.500-08 4.94E-08 1.5FE-07 4.50E-07 NO DATA 7.ItE-06 TEt32 2.08Es95
- 1. 0 3E-05
- 9. 6 t E -0 6 1.520-65 6.44E-05 NO DATA 1.81E-05 1 130 6.00E-06 1.125-15
- 5. 30E-0 6 t.4RE-93 1.45E-05 NO DATA 2.83E-06 1 131 3.59E-05 4.23E-Os 1.MoE-05 1.39f-02 4.94E-05 NO DATA 1.5tE-06 8 132 1.66E-06 3.47E-06
- 1. 2 0 E-0 6 1.5eE-04 3.76E-06 No para 2.73E-06 1 133 1.25E-05 1.82r-05 5.33E-06 3.3tE-01 2.14E-35 NO DATA 3.08E-06 8 134 8.69E-07 1.780-06
- 6. 3 3 E-0 7 4.152-n5 1.99E-06 NO DATA 1.84E-06 I 135 3.64E-06 7.24C-06 2 64E-06.6.49E-n4 9.07E-06 NO DATA 2.62E-06 C5134 3.77E-04 7.03E-04 7.10 E-0 5 NO DATA 1 81E-04 7.42E-05 1.11E-06 C5136 4.59E-05 1.353-04 5.04[-35 NO UATA 5.38L-05 1.10E-05 2.05E-06 i
- 4. 4 3 C -0 5 NO DATA 1.64E-04 6.64E-05 1.91E-06 C5138 4.416-07 7.02E-07 3 79E-0 7 NO DATA 3.90E-07 6.09E-08 1.25E-06 BA139 8.8tE-07 5.e4E-10 2.55E-08 Nu OATA 3.51E-to 3.54E-10 5 58E-05 J
i 1
WP4.15 ODCM-
4 NUCLIJE BONE LIVER T.10LY THYROID KID 4EY LUNG GI-LLI aA14u 1 7tE-04 1.7tE-07 1.AIE-06 NO DATA 4.06E-08 1.05E-G7 4.20E-05 pat 41 4.25E-C7 2.912-10
- 1. 3% E -0 8 NO DATA t.75E-10 1.7FF-tC 5.19E.06 H4147 1.84E-07 1.5sE-10
- 9. 0 6E -0 9 No DATA 8.CtE-It 9.26E-Il 7.59E-07
._.___.._____.________..s_.___
LA140 2.110-08 8.12C-09 2.140-09 NO OATA NO DATA NO DATA 9.77F-05 L A14 2 1.10E-09 4.04E-10 9.6tF-It NO DATA NC OATA NO DATA 6.46F-05 CE141 7.8FE-08 4.80~-08
- 5. 6*,E -0 9 NO DATA 1 48E-05 NO DATA 2.48E-05 CEt43 1.48E-06 9.02E-00 1 1 ? E-0 9 NO CATA
?.96t-09 NO DATA S.73E-05 CE144 2.982-06 1.22C-06 1.67E-07 NO DATA 4.93E-OF NO DATA 1.ftC-04 Pries u.13E-08 1.c4L-08 4.0lE-09 NO DATA 1.13E_nB NO DATA 4.29E-05 P P.14 4 2.74L-10 1.06E-10
- 1. 31E _t t NO DATA 3.R4t-It NO DATA 4.93E-06 rad 147 5.53E-08 5.682-08 1.4aE-09 NO GATA 2.19E-08 rau DATA 1.60E-05 w 187 9.03E.07 6.2de-07
?.1 F E -O F NO DAIA NO DATA NO DATA 1.69E-05 NP211 1.tlE-08 9.93L-10
- 5. 6 t f-10 10 UATA t.98E-09 NO DATA 2.87F-05 WP4.15 ODCM
s O
t APPENDIX D r
k WP4.15 ODCM
l DOSE FACTORS FOR EXPOSURE TO A SEMI-INFINITE CLOUD OF NOBLE GASES 3-afr*(DFf) s-Skin **(DFS )
y-Afr*(OF{}
g y-BodyI*(OFB )
Nuclide g
Kr-83m
2.88E-04 1.~93E-05 7.56E-08 Kr-85m 1.97E-03
~' 1.46E-03 1.23E-03 1.17E-03 Kr-85 1.95E-03 1.34E-03 1.72E-05 1.61E-05 Kr-87 1.03E-02 9.73E-03 6.17E-03 5.92E-03 Kr-88 2.93E-03 2.37E-03 1.52E-02 1.47E-02 Kr-89 1.06E-02 1.01E-02 1.73E-02 1.66E-02 Kr-90 7.83E-03 7.29E-03 1.63E-02 1.56E-02 Xe-131m 1.11E-03 4.76E-04 1.56E-04 9.15E-05 Xe-133m 1.48E-03 9.94E-04 3.27E-04 2.51E-04 Xe-133 1.05E-03 3.06E-04 3.53E-04 2.94E-04 Xe-135m 7.39E-04 7.11E-04 3.36E-03 3.12E-03 Xe-135 2.46E-03 1.86E-03 1.92E-03 1.81E-03 Xe-137 1.27E-02 1.22E-02 1.51E-03 1.42E-03 Xe-138 4.75E-03 4.13E-03 9.21E-03 8.83E-03 Ar-41 3.28E-03 2.69E-03 9.30E-03 8.84E-03 3
mrad-m pC1-yr
- ,7,,,,3 pCl-yr
- 2.88E-04 = 2.88 x 10'4 l
l I
WP4.15 ODCM 6
a -
_. ~. -.
DOSE FACTORS FOR E2POSURE TO A SEMI-INFINITE CLOUD OF NOBLE CASES
- BETA AIR BETA SKIN GAMMA AIR GAMMA WHOLE DOSE FACTOR
-DOSE FACTOR DOSE FACTOR BODY DOSE FACTOR
{
L E
I g
g.
xg g
3 3
3 3
NUCLIDE (arad/yr per uCi/m )
(arem/yr per vC1/m )
(arad/yr per sci /m )
(arem/yr per VCi/m )
Kr-83m' 2.88EM2 **
1.93EM1 7.56E-02 Kr-85m 1.97E+03 1.46E+03-1.23E+03 1.17EM3 Kr-85 1.95E+03 1.34E+03 1.72EMI 1.61E+01 Kr-87 1.03EM4 9.73EM3 6.17E+03 5.92E+03 Kr-88 2.93E+03 2.37E+03 1.52E+04.
1.47E+04 Kr-89 1.06E+04 1.01E+04 1.73E+04 1.66EM4 Kr-90 7.83E+03 7.29E+03 1.63E+04 1.56E+04 Xe-131m 1.11E+03 4.76EM2 1.56E+02 9.15E+01 Xe-133m 1.48E+03 9.94EM2 3.27E+02 2.51EM2 Xe-133
.1.05E+03 3.06EM2 3.53E+02 2.94E+02 Xe-135m 7.39E+02 7.11E+02 3.36EM3 3.12E+03
+
-Xe-135 2.46E+03 1.86E+03 1.92E+03 1.81E+03 Xe-137-1.27E+04 1.22E+04 1.51E+03 1.42E+03 Xe-138 4.75E+03 4.13E+03 9.21E+03 8.83E+03 Ar-41 3.28E+03 2.69E+03 9.30E+03 8.84E+03 Gr-999***
4.00E+03 4.00E+03 6.37E+03 5.43E+03
- From Table B-1, Regulatory Guide 1.109,.Rev. 1, 1977.
2
- 2.88E+02 = 2.88 x 10,
- Parameters to assess a " gross" noble gas ' release, 5 ~ 0.8 MeV, E g ~ 0.56 MeV.
7 WP4.15 ODCM
o APPENDIX E l
l I
1 i
WP4.15 ODCM
o o
LISTING 0F RADIOLOGICAL DECAY CONSTANTS ( A )
1 DECAY DECAY CONSTANT ISOTOPE A. (hrs-1)
- ISO'IVPE
}e II-3 6.40E-6 Ru-106 7.84E-5 C-14 1.38E-8 Ag-110M 1.
E-4 Na-24 4.62E-2 Te-125M 4.
E-4 P-32 2.02E-3 Te-127M
- 2. SE-4 Cr-51 1.04E-3 Te-127 7.41E-2 Mn-54 9 24E-5 Te-129M 8.59E-4 Mn-56 2.69E-1 Te-129 5 97E-1 Fe-55 2 93E-5 Te-131M 2.31E-2 Fe-59 6.47E-4 Te-131 1.66EeO Co-58 4.08E-4 Te-132 8.86E-3 Co-60 1 50E-5 I-130 5.61E-2 Ni-63 8.23E-7 I-131 3.59E-3 Ni-6_5 2.75E-1 I-132 3 01E-1 Cu-64 5 46E-2 I-133 3.33E-2 zn-65 1.18E-4 I-134 7.90E-1 zn-69 7.29E-1 I-135 1.05E-1 Br-J 2 90E-1 Cs-134 3.83E-5 8
Br-m 1.31E+0 Cs-136 2.20E-3 Br-85 1.45E 1 Cs-137 2.62E-6 Rb-86 1 55E-3 Cs-138 1.29E40 Rb-88 2.34E'O Ba-139 5 03E-1 Rb-89 2.74E+O Ba-140 2.26E-3 Sr-89 5 71E-4 Ba-141 2.28E+0 sr-90 2.77E-6 Ba-142 3.89E+O Sr-91 7.29E-2 La-140
E-1
'Y-90 1.08E-2 Ce-141 8.
E-4 Y-91M
- 8. SE-1 Ce-143 2.lOE-2 Y-91 4.
E-4 Ce-144 1.02E-4 Y-92 1.
E-1 Pr-14p 2.13E-3 Y-93 6.
E-2 Pr-144 2.41E+0 Zr-95 4.51E-4 Nd-147 2.61E-3 Zr-97 4.10E-2 W-187 2 90E-2 Nb-95 8.21E-4 Np-239 1.23E-2 Mo-99 1.05E-2 sb-124 6.94E-4 Tc-99M 1.15E-1 Tc-101 2 93EAO Ru-103 7.34E-4 Ru-105 1 56E-1
~
~
- Aj = Radiological Decay Constant a For unlisted nuclides, Aj =.693/Ti, where Ti = Radiological Half-Life 1
- WP4.15 ODCM
_ _ _ _ _ _ _ - _ - _ _ - _ _ _ _ _ _ _ _ _ _ - _ - _